Close

Form 10-Q 3D SYSTEMS CORP For: Mar 31

May 6, 2015 9:27 AM EDT

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

__________________

 

FORM 10‑Q

_______________________________

 

   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2015

 

OR

 

   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________to____________

 

Commission File No. 001-34220

__________________________

 

Picture 1

 

3D SYSTEMS CORPORATION

(Exact name of Registrant as specified in its Charter)

_______________  _____________________________

 

 

 

 

 

 

DELAWARE

 

95‑4431352

(State or Other Jurisdiction of
Incorporation or Organization)

 

(I.R.S. Employer
Identification No.)

333 THREE D SYSTEMS CIRCLE
ROCK HILL, SOUTH CAROLINA

 

29730

(Address of Principal Executive Offices)

 

(Zip Code)

 

(Registrant’s Telephone Number, Including Area Code): (803) 326‑3900

__________________________

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No 

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes  No 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):

 

 

 

 

 

 

 

 

Large accelerated filer

 

Accelerated filer 

 

 

 

 

 

Non-accelerated filer

(Do not check if smaller reporting company)

Smaller reporting company

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b‑2 of the Exchange Act.) Yes  No 

 

APPLICABLE ONLY TO CORPORATE ISSUERS:

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Shares of Common Stock, par value $0.001, outstanding as of April 29, 2015:  111,797,093

 

1


 

 

 

3D SYSTEMS CORPORATION

Quarterly Report on Form 10-Q for the

Quarter Ended March 31, 2015

 

TABLE OF CONTENTS

 

 

 

2

 


 

 

 

 

PART I. — FINANCIAL INFORMATION

 

Item 1.  Financial Statements.

 

3D SYSTEMS CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31,

 

December 31,

(in thousands, except par value)

 

2015

 

2014

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

199,896 

 

$

284,862 

Accounts receivable, net of allowance for doubtful accounts of $13,275 (2015) and $10,300 (2014)

 

 

153,107 

 

 

168,441 

Inventories, net

 

 

114,602 

 

 

96,645 

Prepaid expenses and other current assets

 

 

21,247 

 

 

15,769 

Current deferred income tax asset

 

 

18,755 

 

 

14,973 

Total current assets

 

 

507,607 

 

 

580,690 

Property and equipment, net

 

 

82,737 

 

 

81,881 

Intangible assets, net

 

 

293,481 

 

 

251,561 

Goodwill

 

 

607,570 

 

 

589,537 

Long term deferred income tax asset

 

 

878 

 

 

816 

Other assets, net

 

 

21,154 

 

 

21,485 

Total assets

 

$

1,513,427 

 

$

1,525,970 

LIABILITIES AND EQUITY

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Current portion of debt and capitalized lease obligations

 

$

563 

 

$

684 

Accounts payable

 

 

58,717 

 

 

64,378 

Accrued and other liabilities

 

 

54,426 

 

 

44,219 

Customer deposits

 

 

7,898 

 

 

6,946 

Deferred revenue

 

 

37,769 

 

 

32,264 

Total current liabilities

 

 

159,373 

 

 

148,491 

Long term portion of capitalized lease obligations

 

 

8,581 

 

 

8,905 

Long term deferred income tax liability 

 

 

31,388 

 

 

30,679 

Other liabilities

 

 

33,756 

 

 

34,898 

Total liabilities

 

 

233,098 

 

 

222,973 

Redeemable noncontrolling interests

 

 

8,872 

 

 

8,872 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

Common stock, $0.001 par value, authorized 220,000 shares; issued 112,301 (2015) and 112,233 (2014)

 

 

112 

 

 

112 

Additional paid-in capital

 

 

1,256,452 

 

 

1,245,462 

Treasury stock, at cost: 421 shares (2015) and 709 shares (2014)

 

 

(228)

 

 

(374)

Accumulated earnings

 

 

58,943 

 

 

72,124 

Accumulated other comprehensive loss

 

 

(44,973)

 

 

(24,406)

Total 3D Systems Corporation stockholders' equity

 

 

1,270,306 

 

 

1,292,918 

Noncontrolling interests

 

 

1,151 

 

 

1,207 

Total stockholders’ equity

 

 

1,271,457 

 

 

1,294,125 

Total liabilities, redeemable noncontrolling interests and stockholders’ equity

 

$

1,513,427 

 

$

1,525,970 

 

See accompanying notes to condensed consolidated financial statements.

3

 


 

 

 

3D SYSTEMS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Quarter Ended March 31,

 

(in thousands, except per share amounts)

2015

 

2014

 

Revenue:

 

 

 

 

 

 

Products

$

99,822 

 

$

101,194 

 

Services

 

60,900 

 

 

46,564 

 

Total revenue

 

160,722 

 

 

147,758 

 

Cost of sales:

 

 

 

 

 

 

Products

 

50,476 

 

 

46,816 

 

Services

 

31,262 

 

 

25,470 

 

Total cost of sales

 

81,738 

 

 

72,286 

 

Gross profit

 

78,984 

 

 

75,472 

 

Operating expenses:

 

 

 

 

 

 

Selling, general and administrative

 

74,292 

 

 

48,720 

 

Research and development

 

22,216 

 

 

17,235 

 

Total operating expenses

 

96,508 

 

 

65,955 

 

Income (loss) from operations

 

(17,524)

 

 

9,517 

 

Interest and other expense, net

 

2,567 

 

 

1,048 

 

Income (loss) before income taxes

 

(20,091)

 

 

8,469 

 

Provision (benefit) for income taxes

 

(6,943)

 

 

3,559 

 

Net income (loss)

 

(13,148)

 

 

4,910 

 

Less net income attributable to noncontrolling interests

 

33 

 

 

33 

 

Net income (loss) attributable to 3D Systems Corporation

$

(13,181)

 

$

4,877 

 

 

 

 

 

 

 

 

Other comprehensive income (loss):

 

 

 

 

 

 

Pension adjustments, net of taxes

$

265 

 

$

19 

 

Foreign currency translation loss

 

(20,957)

 

 

(13)

 

Other comprehensive income (loss)

 

(20,692)

 

 

 

Less foreign currency translation gain (loss) attributable to noncontrolling interests

 

(125)

 

 

26 

 

Other comprehensive loss attributable to 3D Systems Corporation

 

(20,567)

 

 

(20)

 

 

 

 

 

 

 

 

Comprehensive income (loss)

 

(33,840)

 

 

4,916 

 

Less comprehensive income (loss) attributable to noncontrolling interests

 

(92)

 

 

59 

 

Comprehensive income (loss) attributable to 3D Systems Corporation

$

(33,748)

 

$

4,857 

 

 

 

 

 

 

 

 

Net income (loss) per share available to 3D Systems Corporation common stockholders — basic and diluted

$

(0.12)

 

$

0.05 

 

 

See accompanying notes to condensed consolidated financial statements.

4

 


 

 

 

 

3D SYSTEMS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

 

 

 

 

 

 

 

Quarter Ended March 31,

(in thousands)

 

2015

 

 

2014

Cash flows from operating activities:

 

 

 

 

 

Net income (loss)

$

(13,148)

 

$

4,910 

Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:

 

 

 

 

 

Benefit of deferred income taxes

 

(10,254)

 

 

(7,610)

Depreciation and amortization

 

19,470 

 

 

12,486 

Non-cash interest on convertible notes

 

 

 

95 

Provision for bad debts

 

2,881 

 

 

1,341 

Stock-based compensation

 

10,329 

 

 

7,276 

Loss on the disposition of property and equipment

 

253 

 

 

286 

Changes in operating accounts:

 

 

 

 

 

Accounts receivable

 

17,986 

 

 

(11,402)

Inventories

 

(20,011)

 

 

(13,034)

Prepaid expenses and other current assets

 

(2,784)

 

 

(7,375)

Accounts payable

 

(5,815)

 

 

4,267 

Accrued and other liabilities

 

(4,373)

 

 

8,273 

Customer deposits

 

1,070 

 

 

976 

Deferred revenue

 

2,535 

 

 

(396)

Other operating assets and liabilities

 

924 

 

 

215 

Net cash provided by (used in) operating activities

 

(937)

 

 

308 

Cash flows from investing activities:

 

 

 

 

 

Purchases of property and equipment

 

(3,693)

 

 

(3,551)

Additions to license and patent costs

 

(203)

 

 

(210)

Cash paid for acquisitions, net of cash assumed

 

(77,984)

 

 

(2,000)

Other investing activities

 

(600)

 

 

(100)

Net cash used in investing activities

 

(82,480)

 

 

(5,861)

Cash flows from financing activities:

 

 

 

 

 

Tax benefits from share-based payment arrangements

 

447 

 

 

5,448 

Proceeds from exercise of stock options and restricted stock, net

 

360 

 

 

484 

Repayment of capital lease obligations

 

(176)

 

 

(44)

Net cash provided by financing activities

 

631 

 

 

5,888 

Effect of exchange rate changes on cash

 

(2,180)

 

 

53 

Net increase (decrease) in cash and cash equivalents

 

(84,966)

 

 

388 

Cash and cash equivalents at the beginning of the period

 

284,862 

 

 

306,316 

Cash and cash equivalents at the end of the period

$

199,896 

 

$

306,704 

 

 

 

 

 

 

Cash interest payments

$

143 

 

$

132 

Cash income tax payments

 

1,707 

 

 

2,407 

Transfer of equipment from inventory to property and equipment, net (a)

 

2,539 

 

 

2,300 

Transfer of equipment to inventory from property and equipment, net (b)

 

1,822 

 

 

16 

Stock issued for acquisitions of businesses

 

 

 

2,000 

 

(a)

Inventory is transferred from inventory to property and equipment at cost when the Company requires additional machines for training or demonstration or for placement into Quickparts’ locations.

(b)

In general, an asset is transferred from property and equipment, net into inventory at its net book value when the Company has identified a potential sale for a used machine.

 

See accompanying notes to condensed consolidated financial statements

 

 

5

 


 

 

 

3D SYSTEMS CORPORATION

CONDENSED CONSOLIDATED STATEMENT OF EQUITY

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock

 

Treasury Stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(In thousands, except par value)

Shares

 

Par Value $0.001

 

Additional Paid In Capital

 

Shares

 

Amount

 

Accumulated Earnings

 

Accumulated Other Comprehensive Income (Loss)

 

Total 3D Systems Corporation Stockholders' Equity

 

Equity Attributable to Noncontrolling Interests

 

Total Stockholders' Equity

Balance at December 31, 2014

112,233 

 

$

112 

 

$

1,245,462 

 

709 

 

$

(374)

 

$

72,124 

 

$

(24,406)

 

$

1,292,918 

 

$

1,207 

 

$

1,294,125 

Tax benefits from share-based payment arrangements

 

 

 

 

447 

 

 

 

 

 

 

 

 

 

447 

 

 

 

 

447 

Issuance (repurchase) of restricted stock, net

286 

 

 

 

 

286 

 

24 

 

 

(22)

 

 

 

 

 

 

264 

 

 

 

 

264 

Issuance of restricted stock from treasury shares

(218)

 

 

 

 

(72)

 

(312)

 

 

168 

 

 

 

 

 

 

96 

 

 

 

 

96 

Stock-based compensation expense

 

 

 

 

10,329 

 

 

 

 

 

 

 

 

 

10,329 

 

 

 

 

10,329 

Net income (loss)

 

 

 

 

 

 

 

 

 

(13,181)

 

 

 

 

(13,181)

 

 

33 

 

 

(13,148)

Noncontrolling interests for business combinations

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

36 

 

 

36 

Pension adjustment

 

 

 

 

 

 

 

 

 

 

 

265 

 

 

265 

 

 

 

 

265 

Foreign currency translation adjustment

 

 

 

 

 

 

 

 

 

 

 

(20,832)

 

 

(20,832)

 

 

(125)

 

 

(20,957)

Balance at March 31, 2015

112,301 

 

$

112 

 

$

1,256,452 

 

421 

 

$

(228)

 

$

58,943 

 

$

(44,973)

(a)

$

1,270,306 

 

$

1,151 

 

$

1,271,457 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(a)

Accumulated other comprehensive loss of $44,973 consists of foreign currency translation loss of $43,027 and a cumulative unrealized pension loss of $1,946.

 

See accompanying notes to condensed consolidated financial statements.

 

 

6


 

 

 

 

3D SYSTEMS CORPORATION

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 (Unaudited)

 

(1)  Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements include the accounts of 3D Systems Corporation and its subsidiaries (collectively, the “Company”). All significant intercompany transactions and balances have been eliminated in consolidation. The unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) and the rules and regulations of the Securities and Exchange Commission (“SEC”) applicable to interim reports. Accordingly, they do not include all the information and notes required by GAAP for complete financial statements and should be read in conjunction with the audited financial statements included in the Company’s Annual Report on Form 10-K (“Form 10-K”) for the year ended December 31, 2014.

 

In the opinion of management, the unaudited condensed consolidated financial statements contain all adjustments, consisting of adjustments of a normal recurring nature, necessary to present fairly the financial position, results of operations and cash flows for the periods presented. The results of operations for the quarter ended March 31, 2015 are not necessarily indicative of the results to be expected for the full year.

 

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results may differ from those estimates and assumptions.

 

Certain prior period amounts presented in the condensed consolidated financial statements and accompanying footnotes have been reclassified to conform to current year presentation.

 

All amounts presented in the accompanying footnotes are presented in thousands, except for per share information.

 

Recent Accounting Pronouncements

 

In April 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs” (“ASU 2015-03”), which changes the presentation of debt issuance costs in financial statements. ASU 2015-03 requires an entity to present such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. Amortization of the costs will continue to be reported as interest expense. It is effective for annual reporting periods beginning after December 15, 2016. Early adoption is permitted. The new guidance will be applied retrospectively to each prior period presented. The Company is currently in the process of evaluating the impact of adoption of ASU 2015-03 on its consolidated balance sheets.

 

No other new accounting pronouncements, issued or effective during the first quarter of 2015, have had or are expected to have a significant impact on the Company’s consolidated financial statements.

 

(2) Acquisitions

 

The Company completed one acquisition in the first quarter of 2015, which is discussed below.

 

On February 9, 2015, the Company acquired 100% of the outstanding shares and voting rights of Cimatron Ltd. (“Cimatron”), a provider of integrated 3D CAD/CAM software and solutions for manufacturing. The fair value of the consideration paid for this acquisition, net of cash acquired, was $77,984, all of which was paid in cash. The operations of Cimatron have been integrated into the Company’s products and service revenues. The fair value of the consideration paid for this acquisition was allocated to the assets purchased and liabilities assumed, based on their estimated fair values as of the acquisition date, with any excess recorded as goodwill, and is included in the table below, which summarizes the first quarter 2015 acquisition. Factors considered in determination of goodwill include synergies, vertical integration and strategic fit for the Company.

 

The acquisition completed in the first quarter is not material relative to the Company’s assets or operating results; therefore, no proforma financial information is provided.

7


 

 

 

The Company’s purchase price allocation for the acquired company is preliminary and subject to revision as more detailed analyses are completed and additional information about the fair value of assets and liabilities becomes available. The amounts related to the acquisition are allocated to the assets acquired and the liabilities assumed and are included in the Company’s unaudited condensed consolidated balance sheet at March 31, 2015 as follows:

 

 

 

 

 

 

 

 

(in thousands)

2015

Fixed assets

$

287 

Other intangible assets, net

 

50,700 

Goodwill

 

37,580 

Other assets, net of cash acquired

 

17,040 

Liabilities

 

(27,623)

Net assets acquired

$

77,984 

 

Subsequent Acquisition

 

On April 2, 2015, the Company acquired 65% of the equity interests in Wuxi Easyway Model Design and Manufacture Co. Ltd., a manufacturing service bureau and distributor of 3D printing and scanning products in China. Under the terms of the agreement, the Company has an option to acquire the remainder of the equity interests between the third and fifth anniversary of the closing.

 

(3)  Inventories

 

Components of inventories, net at March 31, 2015 and December 31, 2014 were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

(in thousands)

2015

 

2014

Raw materials

$

54,489 

 

$

46,850 

Work in process

 

2,338 

 

 

2,304 

Finished goods and parts

 

57,775 

 

 

47,491 

Inventories, net

$

114,602 

 

$

96,645 

 

 

(4)  Property and Equipment

 

Property and equipment at March 31, 2015 and December 31, 2014 were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(in thousands)

2015

 

2014

 

Useful Life (in years)

Land

$

541 

 

$

541 

 

N/A

Building

 

9,373 

 

 

9,370 

 

25

Machinery and equipment

 

93,467 

 

 

84,443 

 

3-7

Capitalized software

 

3,853 

 

 

3,693 

 

3-5

Office furniture and equipment

 

4,566 

 

 

3,478 

 

3-5

Leasehold improvements

 

14,561 

 

 

12,447 

 

Life of lease (a)

Rental equipment

 

498 

 

 

557 

 

5

Construction in progress

 

11,866 

 

 

20,082 

 

N/A

Total property and equipment

 

138,725 

 

 

134,611 

 

 

Less: Accumulated depreciation and amortization

 

(55,988)

 

 

(52,730)

 

 

Total property and equipment, net

$

82,737 

 

$

81,881 

 

 

 

(a)

Leasehold improvements are amortized on a straight-line basis over the shorter of (i) their estimated useful lives and (ii) the estimated or contractual life of the related lease.

 

Depreciation and amortization expense on property and equipment for the quarters ended March 31, 2015 and 2014 was $4,709 and $3,036 respectively.

8

 


 

 

 

(5)  Intangible Assets

 

Intangible assets other than goodwill at March 31, 2015 and December 31, 2014 were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2015

 

2014

 

 

 

 

(in thousands)

Gross

 

Accumulated Amortization

 

Net

 

Gross

 

Accumulated Amortization

 

Net

 

Useful Life (in years)

 

Weighted Average Useful Life Remaining (in years)

Intangible assets with finite lives:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Licenses

$

5,875 

 

$

(5,875)

 

$

 —

 

$

5,875 

 

$

(5,875)

 

$

 —

 

N/A

 

N/A

Patent costs

 

20,949 

 

 

(7,613)

 

 

13,336 

 

 

20,733 

 

 

(7,369)

 

 

13,364 

 

5-20

 

3

Acquired technology

 

71,498 

 

 

(20,687)

 

 

50,811 

 

 

57,383 

 

 

(18,241)

 

 

39,142 

 

3-10

 

4

Internally developed software

 

9,072 

 

 

(5,878)

 

 

3,194 

 

 

9,073 

 

 

(5,517)

 

 

3,556 

 

1-8

 

<1

Customer relationships

 

185,497 

 

 

(39,163)

 

 

146,334 

 

 

157,139 

 

 

(36,975)

 

 

120,164 

 

3-11

 

2

Non-compete agreements

 

35,114 

 

 

(12,637)

 

 

22,477 

 

 

35,469 

 

 

(11,784)

 

 

23,685 

 

3-11

 

3

Trade names

 

26,774 

 

 

(4,684)

 

 

22,090 

 

 

21,800 

 

 

(4,455)

 

 

17,345 

 

2-10

 

5

Other

 

41,983 

 

 

(8,854)

 

 

33,129 

 

 

39,100 

 

 

(6,905)

 

 

32,195 

 

4-10

 

1

Intangible assets with indefinite lives:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trademarks

 

2,110 

 

 

 —

 

 

2,110 

 

 

2,110 

 

 

 

 

2,110 

 

N/A

 

N/A

Total intangible assets

$

398,872 

 

$

(105,391)

 

$

293,481 

 

$

348,682 

 

$

(97,121)

 

$

251,561 

 

1-20

 

4

 

For the quarter ended March 31, 2015 and 2014, the Company capitalized $203 and $210, respectively, of costs incurred to internally develop and extend patents in the United States and various other countries.

 

Amortization expense of intangible assets for the quarter ended March 31, 2015 and 2014 was $14,517 and $9,204 respectively.

 

Annual amortization expense for intangible assets is expected to be $54,467,  $48,813,  $43,796,  $35,663 and $25,876 for the years ended 2015, 2016, 2017, 2018 and 2019, respectively.

 

(6)  Accrued and Other Liabilities

 

Accrued liabilities at March 31, 2015 and December 31, 2014 were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

(in thousands)

2015

 

2014

Compensation and benefits

$

25,507 

 

$

20,726 

Vendor accruals

 

14,858 

 

 

10,451 

Accrued professional fees

 

1,344 

 

 

532 

Accrued taxes

 

8,403 

 

 

8,577 

Royalties payable

 

1,427 

 

 

1,796 

Accrued interest

 

42 

 

 

43 

Accrued earnouts related to acquisitions

 

271 

 

 

185 

Accrued other

 

2,574 

 

 

1,909 

Total

$

54,426 

 

$

44,219 

 

Other liabilities at March 31, 2015 and December 31, 2014 were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

(in thousands)

2015

 

2014

Defined benefit pension obligation

$

6,307 

 

$

7,062 

Long term tax liability

 

3,083 

 

 

2,029 

Long term earnouts related to acquisitions

 

8,972 

 

 

8,970 

Long term deferred revenue

 

7,911 

 

 

7,627 

Other long term liabilities

 

7,483 

 

 

9,210 

Total

$

33,756 

 

$

34,898 

 

 

 

9

 


 

 

 

(7)  Hedging Activities and Financial Instruments

 

The Company conducts business in various countries using both the functional currencies of those countries and other currencies to effect cross border transactions. As a result, the Company is subject to the risk that fluctuations in foreign exchange rates between the dates that those transactions are entered into and their respective settlement dates will result in a foreign exchange gain or loss. When practicable, the Company endeavors to match assets and liabilities in the same currency on its balance sheet and those of its subsidiaries in order to reduce these risks. When appropriate, the Company enters into foreign currency contracts to hedge exposures arising from those transactions. The Company has elected not to prepare and maintain the documentation to qualify for hedge accounting treatment under Accounting Standards Codification (“ASC”) 815, “Derivatives and Hedging,” and therefore, all gains and losses (realized or unrealized) are recognized in "Interest and other expense, net”  in the condensed consolidated statements of operations and comprehensive income (loss). Depending on their fair value at the end of the reporting period, derivatives are recorded either in prepaid expenses and other current assets or in accrued liabilities on the condensed consolidated balance sheet.

 

There were no foreign currency contracts outstanding at March 31, 2015 or at December 31, 2014. 

 

The condensed consolidated statements of operations for the quarters ended March 31, 2015 and 2014 include a foreign currency transaction loss of $2,194 and $205, respectively, which is included in interest and other expense, net.

 

The total impact of foreign currency translation on accumulated other comprehensive income (loss) for the quarters ended March 31, 2015 and 2014, reflects  a loss of $20,832 and $13, respectively.

 

(8) Borrowings

 

Credit Facility 

 

On October 10, 2014, the Company and certain of its subsidiaries entered into a $150,000 five-year revolving, unsecured credit facility (the “Credit Agreement”) with PNC Bank, National Association, as Administrative Agent, PNC Capital Markets LLC, as Sole Lead Arranger and Sole Bookrunner, HSBC Bank USA, N.A., as Syndication Agent, and the other lenders party thereto (collectively, the “Lenders”). The Credit Agreement comprises a revolving loan facility that provides for advances in the initial aggregate principal amount of up to $150,000 (the “Credit Facility”).  Subject to certain terms and conditions contained in the Credit Agreement, the Company may, at its option and subject to customary conditions, request an increase in the aggregate principal amount available under the Credit Facility by an additional $75,000.  The Credit Agreement includes provisions for the issuance of letters of credit and swingline loans.

 

The Credit Agreement is guaranteed by certain of the Company’s material domestic subsidiaries (the “Guarantors”).  Pursuant to the Credit Agreement, the Guarantors guarantee to the Lenders, among other things, all of the obligations of the Company and each other Guarantor under the Credit Agreement.  From time to time, the Company may be required to cause additional material domestic subsidiaries to become Guarantors under the Credit Agreement. 

 

Generally, amounts outstanding under the Credit Facility bear interest, at the Company’s option, at either the Base Rate or the LIBOR Rate, in each case, plus an applicable margin.  Base Rate advances bear interest at a rate per annum equal to the sum of (i) the highest of (A) the Administrative Agent’s prime rate, (B) the Federal Funds Open Rate plus 0.5% or (C) the Daily LIBOR Rate for a one month interest period plus 1%, and (ii) an applicable margin that ranges from 0.25% to 0.50% based upon the Company’s consolidated total leverage ratio. LIBOR Rate advances bear interest at a rate based upon the London interbank offered rate for the applicable interest period, plus an applicable margin that ranges from 1.25% to 1.50% based upon the Company’s consolidated total leverage ratio. Under the terms of the Credit Agreement, (i) accrued interest on each loan bearing interest at the Base Rate is payable quarterly in arrears and (ii) accrued interest on each loan bearing interest at the LIBOR Rate is payable in arrears on the earlier of (A) quarterly and (B) the last day of each applicable interest payment date for each loan. The Credit Facility is scheduled to mature on October 10, 2019, at which time all amounts outstanding thereunder will be due and payable. 

  

The Company is required to pay certain fees in connection with the Credit Facility, including a quarterly commitment fee equal to the product of the amount of the average daily available revolving commitments under the Credit Agreement multiplied by a percentage that ranges from 0.20% to 0.25% depending upon the Company’s leverage ratio, as well as customary administrative fees. 

10

 


 

 

 

The Credit Agreement contains customary representations, warranties, covenants and default provisions for a Credit Facility of this type, including, but not limited to, financial covenants, limitations on liens and the incurrence of debt, covenants to preserve corporate existence and comply with laws and covenants regarding the use of proceeds of the Credit Facility. The financial covenants include a maximum consolidated total leverage ratio, which is the ratio of consolidated total funded indebtedness to consolidated EBITDA (earnings before interest, taxes, depreciation and amortization expense), as defined in the Credit Agreement, of 3.00 to 1.00, and a minimum interest coverage ratio, which is the ratio of Consolidated EBITDA to cash interest expense, of 3.50 to 1.00.  The Company is only required to be in compliance with the financial covenants as of the end of any fiscal quarter in which there are any loans outstanding at any time during such fiscal quarter. 

 

The payment of dividends on the Company’s common stock is restricted under provisions of the Credit Facility, which limits the amount of cash dividends that the Company may pay in any one fiscal year to $30,000.  The Company currently does not pay, and has not paid, any dividends on their common stock, and currently intends to retain any future earnings for use in their business. 

 

There was no outstanding balance on the Credit Facility as of March 31, 2015 and December 31, 2014.

 

Capitalized Lease Obligations

 

The Company’s capitalized lease obligations include lease agreements that were entered into during 2006 with respect to the Company’s corporate headquarters located in Rock Hill, SC, and lease agreements assumed in the LayerWise acquisition. Total capitalized lease obligations decreased to $9,078 at March 31, 2015 from $9,434 at December 31, 2014, primarily due to the normal scheduled timing of payments.

 

Other debt

 

In connection with its acquisition of LayerWise, the Company assumed a portion of LayerWise’s outstanding bank debt, consisting of revolving credit facilities and term loans. The term loans bear interest at rates ranging from 1.34% to 5.40% as of March 31, 2015. The outstanding balance on the term loans was $66 and $127 as of March 31, 2015 and December 31, 2014, respectively. There were no borrowings outstanding under the revolving credit facilities as of March 31, 2015 or December 31, 2014. There is a 0.125% commitment fee on the unused portion of the facilities.

 

(9)  Stock-based Compensation Plans

 

The Company records stock-based compensation expense in selling, general and administrative expenses in the condensed consolidated statements of operations and comprehensive income (loss). Stock-based compensation expense for the quarter ended March 31, 2015 and 2014 was as follows:

 

 

 

 

 

 

 

 

Quarter Ended March 31,

(in thousands)

2015

 

2014

Restricted stock awards

$

10,329 

 

$

7,276 

 

The number of shares and units of restricted common stock awarded and the weighted average fair value per share and unit during the quarter ended March 31, 2015 and 2014 were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quarter Ended March 31,

 

 

2015

 

 

2014

(in thousands, except per share amounts)

 

Number of Shares/Units

 

Weighted Average Fair Value

 

 

Number of Shares/Units

 

Weighted Average Fair Value

Restricted stock awards:

 

 

 

 

 

 

 

 

 

 

 

Granted under the 2004 Incentive Stock Plan

 

273 

 

$

28.62 

 

 

233 

 

$

80.82 

 

During the quarter ended March 31, 2015, the Company granted restricted stock awards covering 273 shares and units of common stock pursuant to the Company’s 2004 Incentive Stock Plan. As of March 31, 2015, 148 shares or units under awards remained subject to acceptance and 60 shares under awards were granted to executive officers of the Company during the quarter. During the quarter ended March 31, 2014, the Company granted restricted stock awards covering 233 shares of common stock pursuant to the Company’s 2004 Incentive Stock Plan, of which 30 shares were awarded to executive officers of the Company.

 

No shares or units of common stock pursuant to the Company’s 2004 Restricted Stock Plan were granted to Non-Employee Directors during the first quarter of 2015 or 2014.

 

11

 


 

 

 

(10)  International Retirement Plan

 

The following table shows the components of net periodic benefit costs and other amounts recognized in the condensed consolidated statements of operations and comprehensive income (loss) for the quarter ended March 31, 2015 and 2014:

 

 

 

 

 

 

 

 

Quarter Ended March 31,

(in thousands)

2015

 

2014

Service cost

$

47 

 

$

45 

Interest cost

 

62 

 

 

62 

Total

$

109 

 

$

107 

 

 

(11)  Earnings (Loss) Per Share

 

The Company presents basic and diluted earnings per share (“EPS”) amounts. Basic EPS is calculated by dividing net income (loss) attributable to 3D Systems Corporation available to common stockholders by the weighted average number of common shares outstanding during the applicable period. Diluted EPS is calculated by dividing net income (loss) by the weighted average number of common and common equivalent shares outstanding during the applicable period. For the quarter ended March 31, 2015, restricted stock units were antidilutive because of the net loss, and, as such, their effect has not been included in the calculation of diluted earnings (loss) per share.

 

The following table reconciles basic weighted average outstanding shares to diluted weighted average outstanding shares at March 31, 2015 and 2014:

 

 

 

 

 

 

 

 

 

Quarter Ended March 31,

(in thousands, except per share amounts)

2015

 

2014

Numerator for basic and diluted net earnings per share:

 

 

 

 

 

Net income (loss) attributable to 3D Systems Corporation

$

(13,181)

 

$

4,877 

 

 

 

 

 

 

Denominator for basic and diluted net earnings per share:

 

 

 

 

 

Weighted average shares

 

111,731 

 

 

103,546 

 

 

 

 

 

 

Earnings (loss) per share, basic and diluted

$

(0.12)

 

$

0.05 

 

 

 

 

 

 

Interest expense excluded from diluted earnings per share calculation (a)

$

 

$

156 

5.50% Convertible notes shares excluded from diluted earnings per share calculation (a)

 

 

 

876 

 

(a)

Average outstanding diluted earnings per share calculation excludes shares that may be issued upon conversion of the outstanding senior convertible notes since the effect of their inclusion would have been anti-dilutive.

 

For the quarter ended March 31, 2015, average common shares for basic and diluted loss per share was 111,731 and basic and diluted loss per share was $0.12.  For the quarter ended March 31, 2014, average common shares for basic and diluted earnings per share was 103,546 and basic and diluted earnings per share was $0.05.

 

(12)  Fair Value Measurements

 

ASC 820, “Fair Value Measurements and Disclosures,” defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs that may be used to measure fair value:

 

·

Level 1 - Quoted prices in active markets for identical assets or liabilities;

 

·

Level 2 - Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or

 

·

Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

12

 


 

 

 

For the Company, the above standard applies to cash equivalents. The Company utilizes the market approach to measure fair value for its financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.

 

Assets and liabilities measured at fair value on a recurring basis are summarized below:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair Value Measurements as of March 31, 2015

(in thousands)

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

Description

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents (a) 

$

87,920 

 

$

 

$

 

$

87,920 

Redeemable noncontrolling interests (b)

$

 

$

 

$

8,872 

 

$

8,872 

 

(a)

Cash equivalents include funds held in money market instruments and are reported at their current carrying value, which approximates fair value due to the short-term nature of these instruments and are included in cash and cash equivalents in the consolidated balance sheet.

(b)

Redeemable noncontrolling interests represents a put option that owners of interests in a certain subsidiary have the right, in certain circumstances, to require the Company to acquire either a portion of, or all of, the remaining ownership interests held by them. The Company determines the fair value of the redeemable noncontrolling interests based on unobservable inputs considering the assumptions that market participants would make in pricing the obligation. Given the significance of the unobservable inputs, the valuations are classified in level 3 of the fair value hierarchy. See Note 15.

 

The Company did not have any transfers of assets and liabilities between Level 1, Level 2 and Level 3, of the fair value measurement hierarchy during the quarter ended March 31, 2015.

 

In addition to the financial assets included in the above table, certain of our non-financial assets and liabilities are to be initially measured at fair value on a non-recurring basis. This includes items such as non-financial assets and liabilities initially measured at fair value in a business combination (but not measured at fair value in subsequent periods) and non-financial, long-lived assets measured at fair value for an impairment assessment. In general, non-financial assets and liabilities including goodwill, other intangible assets and property and equipment are measured at fair value when there is an indication of impairment and are recorded at fair value only when impairment is recognized. The Company has not recorded any impairments related to such assets and has had no other significant non-financial assets or non-financial liabilities requiring adjustments or write-downs to fair value as of March 31, 2015 or December 31, 2014.

 

(13)  Income Taxes

 

The Company’s effective tax rates were 34.6% and 42.0% for the quarters ended March 31, 2015 and 2014, respectively.

 

The Company has not provided for any taxes on the unremitted earnings of its foreign subsidiaries, as the Company intends to permanently reinvest all such earnings outside of the U.S. We believe a calculation of the deferred tax liability associated with these undistributed earnings is impracticable.

 

Tax years 2011 through 2014 remain subject to examination by the U.S. Internal Revenue Service. The Company has utilized U.S. loss carryforwards causing the years 1997 to 2007 to be subject to examination. The Company files income tax returns (which are open to examination beginning in the year shown in parentheses) in Australia (2009), Belgium (2010), Brazil (2014), China (2010), France (2011), Germany (2011), India (2012), Israel (2010), Italy (2009), Japan (2008), Korea (2009), Mexico (2014), Netherlands (2007), Switzerland (2008), the United Kingdom (2009) and Uruguay (2014).

 

(14)  Segment Information

 

The Company operates in one reportable business segment. The Company conducts its business through subsidiaries in the United States, a subsidiary in Israel that operates a research and production facility and sales and service offices, a subsidiary in Switzerland that operates a research and production facility, subsidiaries in France and Brazil that operate production facilities and sales and service offices, and other sales and service offices in Europe (Belgium, Germany, the United Kingdom, Italy and the Netherlands), Israel and in Asia Pacific (Australia, China, India, Japan and Korea). The Company has historically disclosed summarized financial information for the geographic areas of operations as if they were segments in accordance with ASC 280, “Segment Reporting.” Financial information concerning the Company’s geographical locations is based on the location of the selling entity. Such summarized financial information concerning the Company’s geographical operations is shown in the following tables:

13

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quarter Ended March 31,

(in thousands)

 

2015

 

2014

Revenue from unaffiliated customers:

 

 

 

 

 

 

Americas

 

$

86,262 

 

$

68,032 

Germany

 

 

21,250 

 

 

23,825 

Other EMEA

 

 

27,454 

 

 

23,739 

Asia Pacific

 

 

25,756 

 

 

32,162 

Total

 

$

160,722 

 

$

147,758 

 

 

 

 

 

 

 

 

 

 

 

Quarter Ended March 31,

(in thousands)

 

2015

 

2014

Products

 

$

62,715 

 

$

60,753 

Materials

 

 

37,107 

 

 

40,441 

Services

 

 

60,900 

 

 

46,564 

Total revenue

 

$

160,722 

 

$

147,758 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quarter Ended March 31, 2015

 

 

Intercompany Sales to

(in thousands)

 

Americas

 

Germany

 

Other EMEA

 

Asia Pacific

 

Total

Americas

 

$

480 

 

$

10,134 

 

$

5,837 

 

$

4,973 

 

$

21,424 

Germany

 

 

 

 

 —

 

 

804 

 

 

 

 

804 

Other EMEA

 

 

14,915 

 

 

654 

 

 

864 

 

 

646 

 

 

17,079 

Asia Pacific

 

 

626 

 

 

 

 

13 

 

 

758 

 

 

1,397 

Total

 

$

16,021 

 

$

10,788 

 

$

7,518 

 

$

6,377 

 

$

40,704 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quarter Ended March 31, 2014

 

 

Intercompany Sales to

(in thousands) 

 

Americas

 

Germany

 

Other EMEA

 

Asia Pacific

 

Total

Americas

 

$

 —

 

$

10,937 

 

$

4,947 

 

$

2,346 

 

$

18,230 

Germany

 

 

409 

 

 

 

 

1,478 

 

 

 

 

1,887 

Other EMEA

 

 

10,043 

 

 

1,330 

 

 

332 

 

 

555 

 

 

12,260 

Asia Pacific

 

 

482 

 

 

 

 

 

 

682 

 

 

1,164 

Total

 

$

10,934 

 

$

12,267 

 

$

6,757 

 

$

3,583 

 

$

33,541 

 

 

 

 

 

 

 

 

 

 

 

Quarter Ended March 31,

(in thousands)

 

2015

 

2014

Income (loss) from operations:

 

 

 

 

 

 

Americas

 

$

(23,106)

 

$

(2,030)

Germany

 

 

1,840 

 

 

197 

Other EMEA

 

 

(1,335)

 

 

2,401 

Asia Pacific

 

 

5,584 

 

 

9,067 

Subtotal

 

 

(17,017)

 

 

9,635 

Inter-segment elimination

 

 

(507)

 

 

(118)

Total

 

$

(17,524)

 

$

9,517 

 

14

 


 

 

 

 

 

 

 

 

 

 

 

March 31,

 

December 31,

(in thousands)

2015

 

2014

Assets:

 

 

 

 

 

Americas

$

920,092 

 

$  

1,018,113 

Germany 

 

53,448 

 

 

47,524 

Other EMEA

 

467,263 

 

 

382,259 

Asia Pacific 

 

72,624 

 

 

78,074 

Total

$

1,513,427 

 

$

1,525,970 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31,

 

December 31,

(in thousands)

2015

 

2014

Cash and cash equivalents:

 

 

 

 

 

Americas

$

149,629 

 

$  

245,219 

Germany

 

13,419 

 

 

6,640 

Other EMEA

 

22,231 

 

 

15,556 

Asia Pacific 

 

14,617 

 

 

17,447 

Total

$

199,896 

 

$

284,862 

 

(15)  Commitments and Contingencies

 

The Company leases office space and certain furniture and fixtures under various non-cancelable operating leases. Rent expense under operating leases was $3,204 and $2,311 for the quarters ended March 31, 2015 and 2014, respectively.

 

As of March 31, 2015, the Company has supply commitments on printer assemblies for the second quarter of 2015 that total  $77,623, compared to $56,620 at December 31, 2014.

 

Certain of the Company’s acquisitions contain earnout provisions under which the sellers of the acquired businesses can earn additional amounts. The total liabilities recorded for these earnouts as of March 31, 2015 and December 31, 2014 was $9,243 and $9,155, respectively.

 

Put Options

 

Owners of interests in a certain subsidiary have the right in certain circumstances to require the Company to acquire either a portion of or all of the remaining ownership interests held by them. The owners’ ability to exercise any such “put option” right is subject to the satisfaction of certain conditions, including conditions requiring notice in advance of exercise. In addition, these rights cannot be exercised prior to a specified exercise date. The exercise of these rights at their earliest contractual date would result in obligations of the Company to fund the related amounts in 2019.

 

Management estimates, assuming that the subsidiary owned by the Company at March 31, 2015, performs over the relevant future periods at their forecasted earnings levels, that these rights, if exercised, could require the Company, in future periods, to pay approximately $8,872 to the owners of such rights to acquire such ownership interests in the relevant subsidiary. This amount has been recorded as redeemable noncontrolling interests on the balance sheet at March 31, 2015 and December 31, 2014. The ultimate amount payable relating to this transaction will vary because it is dependent on the future results of operations of the subject business.

 

The following table presents changes in redeemable noncontrolling interests:

 

 

 

 

 

 

 

   

(in thousands)

March 31,

2015

 

December 31,

2014

Beginning balance

$

8,872 

 

$

Changes in redemption value

 

            —

 

 

8,550 

Currency translation adjustments

 

 

 

322 

Ending balance

$

8,872 

 

$

8,872 

15

 


 

 

 

Litigation 

 

The Company is involved in various legal matters incidental to its business. The Company believes, after consulting with counsel, that the disposition of these legal matters will not have a material effect on our consolidated results of operations or consolidated financial position. 

 

Indemnification

 

In the normal course of business the Company periodically enters into agreements to indemnify customers or suppliers against claims of intellectual property infringement made by first parties arising from the use of the Company’s products. Historically, costs related to these indemnification provisions have not been significant and we are unable to estimate the maximum potential impact of these indemnification provisions on our future results of operations.

 

To the extent permitted under Delaware law, the Company indemnifies directors and officers for certain events or occurrences while the director or officer is, or was, serving at the Company’s request in such capacity, subject to limited exceptions. The maximum potential amount of future payments the Company could be required to make under these indemnification obligations is unlimited; however, the Company has directors and officers insurance coverage that may enable the Company to recover future amounts paid, subject to a deductible and the policy limits. There is no assurance that the policy limits will be sufficient to cover all damages, if any.

 

(16)  Accumulated Other Comprehensive Income (Loss)

 

The changes in the balances of accumulated other comprehensive income (loss) by component are as follows:

 

 

 

 

 

 

 

 

 

 

 

(in thousands)

Foreign currency translation adjustment

 

Defined benefit pension plan

 

 

Total

Balance at December 31, 2014

$

(22,195)

 

$

(2,211)

 

$

(24,406)

Other comprehensive income (loss)

 

(20,832)

 

 

265 

 

 

(20,567)

Balance at March 31, 2015

$

(43,027)

 

$

(1,946)

 

$

(44,973)

 

The amounts presented above are included in other comprehensive income (loss) and are net of taxes. For additional information about foreign currency translation, see Note 7. For additional information about the pension plan, see Note 10.

 

(17)  Noncontrolling Interests

 

As of March 31, 2015, the Company owned approximately 95% of the capital and voting rights of Phenix Systems, a global provider of direct metal selective laser sintering 3D printers. Phenix Systems was acquired on July 15, 2013.

 

As of March 31, 2015, the Company owned approximately 70% of the capital and voting rights of Robtec, an additive manufacturing service bureau and distributor of 3D printing and scanning products.  Robtec was acquired on November 25, 2014.

 

(18)  Subsequent Event

 

On April 2, 2015, the Company acquired 65% of the equity interests in Wuxi Easyway Model Design and Manufacture Co. Ltd, a manufacturing service bureau and distributor of 3D printing and scanning products in China. Under the terms of the agreement, the Company has an option to acquire the remainder of the equity interests between the third and fifth anniversary of the closing.

16

 


 

 

 

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

This discussion should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included in Item 1 of this Quarterly Report on Form 10-Q (“Form 10-Q”).

 

We are subject to a number of risks and uncertainties that may affect our future performance that are discussed in greater detail in the sections entitled “Forward-Looking Statements” and “Cautionary Statements and Risk Factors” at the end of this Item 2 and that are discussed or referred to in Item 1A of Part II of this Form 10-Q.

 

Business Overview

 

We provide the most advanced and comprehensive 3D digital design and fabrication solutions available today, including 3D printers, print materials and cloud-sourced custom parts. Our powerful ecosystem transforms entire industries by empowering professionals and consumers everywhere to bring their ideas to life using our vast material selection, including plastics, metals, ceramics and edibles.

   

Our leading personalized medicine capabilities include end-to-end simulation, training and planning, and printing of surgical instruments and devices for personalized surgery and patient specific medical and dental devices. Our democratized 3D digital design, fabrication and inspection products provide seamless interoperability and incorporate the latest immersive computing technologies. Our products and services disrupt traditional methods, deliver improved results and empower our customers to manufacture the future now.

 

Recent Developments 

 

In January 2015, we launched the full-color Cube Pro C at the International Consumer Electronics Show. This is the first plastic jet printer that is capable of printing in full color. The Cube Pro C is part of our consumer portfolio and is ideal for classroom, home and the engineer’s desktop. We also showcased our new Touch™ haptic 3D stylus. The Touch stylus comes with an OpenHaptics Software Developer Kit for digital design and virtual gaming and is an easy to use, powerful perceptual device that provides a virtual sculpting experience and is ideal for designers, artists, students, gamers and hobbyists.

 

In February 2015, we completed the acquisition of all the outstanding shares of Cimatron Ltd. (“Cimatron”), a provider of integrated 3D CAD/CAM software products and solutions for manufacturing. The acquisition of Cimatron adds complementary technology, extends our sales coverage globally and multiplexes cross-selling opportunities.

 

In February 2015, we announced the availability of the ProJet 3510 DP Pro, an all-in-one 3D printer designed for healthcare applications. The latest in our MultiJet line, the ProJet 3510 DP Pro gives medical and dental labs the power to print precision dental wax-ups, durable implant drill guides, temperature-resistant, thermo-formable orthodontic patterns and crown and bridge molds interchangeably, at up to twice the throughput of today’s printers.

 

In April 2015, we acquired 65% of the equity interests in Wuxi Easyway Model Design and Manufacture Co. Ltd., a manufacturing service bureau and distributor of 3D printing and scanning products in China. Easyway brings us sales and service coverage, service bureau production capabilities and relationships with leading Chinese automotive, medical and consumer goods companies.

17

 


 

 

 

 

Results of Operations

 

Summary of 2015 financial results

 

Revenue for the first quarter of 2015 increased by 8.8%, or $13.0 million, to $160.7 million compared to $147.8 million in the first quarter of 2014. These results primarily reflected growth in services revenue, driven by software and healthcare services.  

 

Products revenue increased by $2.0 million, or 3.2%, from the first quarter of 2014, to $62.7 million, driven by increased demand for consumer printers and expanded healthcare and software products.

 

Materials revenue for the first quarter of 2015 was $37.1 million, a decrease of $3.3 million, or 8.3%, from the first quarter of 2014. This decrease was driven by lower design and manufacturing printer sales during the quarter coupled with an unfavorable impact of foreign currency translation.

 

Services revenue increased by $14.3 million, or 30.8%, from the first quarter of 2014, to $60.9 million. The increase in services revenue primarily reflects the addition of healthcare services, coupled with growing Quickparts, consumer and software services.

 

We calculate organic growth by comparing this year’s total revenue for the period, excluding the revenue recognized from all acquired businesses that we have owned for less than twelve months, to last year’s total revenue for the period. Once we have owned a business for one year, the revenue is included in organic growth. Organic growth is calculated based on total revenue for the prior year period. In the first quarter of 2015, organic revenue decreased by 7.4%, compared to organic growth of 28.1% for the first quarter of 2014.

 

Healthcare revenue includes sales of products, materials, and services for health-related applications, including simulation, training and planning, and printing of surgical instruments and medical and dental devices for personalized medicine. For the first quarter of 2015, healthcare revenue increased by 38.4% and made up 18.7%, or $30.0 million, of our total revenue compared to 14.7%, or $21.7 million, in the first quarter of 2014, primarily due to our increased penetration and expansion of healthcare applications, including the addition of Simbionix, Medical Modeling and Layerwise.

 

Consumer revenue includes sales of our Cube® series 3D printers and their related print materials, Sense 3D scanners and other products and services related to consumer products and retail channels. For the first quarter of 2015, consumer revenue increased 64.5% to $15.9 million, or 9.9% of our total revenue, compared to $9.7 million, or 6.5% of total revenue, in the first quarter of 2014.

 

Gross profit in the first quarter of 2015 increased by $3.5 million, or 4.7% from the first quarter of 2014, to $79.0 million, reflecting higher revenue from services. Our gross profit margin was 49.1% in the first quarter of 2015, compared to 51.1% in the first quarter of 2014,  reflecting current sales mix and timing of sales.

 

Our total operating expenses increased by $30.5 million in the first quarter of 2015, to $96.5 million, from $66.0 million in the same quarter of 2014. The increase reflected higher selling, general and administrative expenses primarily due to increased compensation expenses and acquisition costs. The increase also reflects a $5.0 million increase in research and development expenses related to our portfolio expansion and development of new products.

 

Our operating loss for the first quarter of 2015 was $17.5 million, compared to operating income of $9.5 million in the first quarter of 2014.  This was primarily due to lower gross profit margin and higher operating expenses as discussed in more detail below.

 

Our operating activities used $0.9 million of cash during the first quarter of 2015, which is discussed in further detail below. We used $82.5 million to fund our strategic investing activities, including acquisition costs. Financing activities during the first quarter of 2015 generated $0.6 million of cash. In total, our unrestricted cash balance at March 31, 2015 was $199.9 million compared to $284.9 million at December 31, 2014.

18

 


 

 

 

First quarter comparison of revenue by class of product and service

 

Table 1 below sets forth revenue and percentage of revenue by class of product and service:

 

Table 1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Dollars in thousands)

 

Products

 

Materials

 

Services

 

Totals

Revenue – 1st quarter 2014

 

$

60,753 

 

41.1 

%

 

$

40,441 

 

27.4 

%

 

$

46,564 

 

31.5 

%

 

$

147,758 

 

100 

%

Change in revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Volume

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Core products and services

 

 

7,359 

 

12.1 

 

 

 

(3,061)

 

(7.6)

 

 

 

21,570 

 

46.3 

 

 

 

25,868 

 

17.5 

 

New products and services

 

 

(912)

 

(1.5)

 

 

 

(9,959)

 

(24.6)

 

 

 

(3,488)

 

(7.5)

 

 

 

(14,359)

 

(9.7)

 

Price/Mix

 

 

493 

 

0.8 

 

 

 

12,671 

 

31.3 

 

 

 

 

 

 

 

13,164 

 

8.9 

 

Foreign currency translation

 

 

(4,978)

 

(8.2)

 

 

 

(2,985)

 

(7.4)

 

 

 

(3,746)

 

(8.0)

 

 

 

(11,709)

 

(7.9)

 

Net change

 

 

1,962 

 

3.2 

 

 

 

(3,334)

 

(8.3)

 

 

 

14,336 

 

30.8 

 

 

 

12,964 

 

8.8 

 

Revenue – 1st quarter 2015

 

$

62,715 

 

39.0 

%

 

$

37,107 

 

23.1 

%

 

$

60,900 

 

37.9 

%

 

$

160,722 

 

100 

%

 

We earn revenues from the sale of products, materials and services. On a consolidated basis, revenue for the first quarter of 2015 increased by $13.0 million, or 8.8%, compared to the first quarter of 2014, primarily reflecting an increase in services revenue.

 

The $2.0 million increase in revenue from products compared to the first quarter of 2014 is driven by increased demand for consumer printers, software and expanded healthcare products. Certain resellers may purchase stock inventory in the ordinary course of business. For the first quarter of 2015, we estimate that revenue related to reseller inventory amounted to approximately 5% of total revenue, compared to approximately 10% of total revenue for the first quarter of 2014.

 

In addition to printers, the products category includes software products, perceptual and haptic devices, Vidar digitizers and Simbionix simulators. Software revenue, including perceptual and haptic devices, contributed $8.9 million and $5.8 million of products revenue in 2015 and 2014, respectively.

 

Due to the relatively high price of certain professional printers and a corresponding lengthy selling cycle and relatively low unit volume of the higher priced professional printer sales in any particular period, a shift in the timing and concentration of orders and shipments from one period to another can affect reported revenue in any given period. Revenue reported in any particular period is also affected by timing of revenue recognition under rules prescribed by generally accepted accounting principles.

 

Our revenue from materials decreased by $3.3 million, including a $3.0 million unfavorable impact of foreign currency. Sales of integrated materials decreased by 2.6% to $28.7 million and represented 77.3% of total materials revenue in the first quarter of 2015, compared to 72.7% in the first quarter of 2014.  

 

The increase in services revenue primarily reflects the addition of Medical Modeling and Simbionix revenue and organic and acquired growth from our Quickparts solutions, coupled with growing consumer and software services. Service revenue from Quickparts increased 9.8% to $31.6 million for the first quarter of 2015, compared to $28.8 for the first quarter of 2014.  Software services contributed $7.7 million of revenue in the first quarter of 2015 compared to $3.2 million in the first quarter of 2014.

 

At March 31, 2015 our backlog was $37.8 million, compared to backlog of $46.5 million at December 31, 2014 and $28.8 million at March 31, 2014. Production and delivery of our printers is generally not characterized by long lead times, backlog is more dependent on timing of customers’ requested deliveries. In addition, Quickparts services lead time and backlog depends on whether orders are for rapid prototyping or longer-range production runs. The backlog at March 31, 2015 includes $14.1 million of Quickparts services orders, compared to $8.3 million at March 31, 2014.

 

In addition to changes in sales volumes, including the impact of revenue from acquisitions, there are two other primary drivers of changes in revenues from one period to another: the combined effect of changes in product mix and average selling prices, sometimes referred to as price and mix effects, and the impact of fluctuations in foreign currencies.

 

As used in this Management’s Discussion and Analysis, the price and mix effects relate to changes in revenue that are not able to be specifically related to changes in unit volume. Among these changes are changes in the product mix of our materials and our printers as the trend toward smaller, lower-priced printers has continued and the influence of new printers and print materials on our operating results has grown.

19

 


 

 

 

Change in first quarter revenue by geographic region

 

Table 2 sets forth the change in revenue by geographic area for the first quarter of 2015 compared to the first quarter of 2014:

 

Table 2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Dollars in thousands)

 

Americas

 

EMEA

 

Asia Pacific

 

Total

Revenue – 1st quarter 2014

 

$

68,032 

 

46.0 

%

 

$

47,564 

 

32.2 

%

 

$

32,162 

 

21.8 

%

 

$

147,758 

 

100 

%

Change in revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Volume

 

 

18,549 

 

27.3 

 

 

 

(1,194)

 

(2.5)

 

 

 

(5,846)

 

(18.2)

 

 

 

11,509 

 

7.8 

 

Price/Mix

 

 

274 

 

0.4 

 

 

 

11,494 

 

24.2 

 

 

 

1,396 

 

4.3 

 

 

 

13,164 

 

8.9 

 

Foreign currency translation

 

 

(593)

 

(0.9)

 

 

 

(9,160)

 

(19.3)

 

 

 

(1,956)

 

(6.1)

 

 

 

(11,709)

 

(7.9)

 

Net change

 

 

18,230 

 

26.8 

 

 

 

1,140 

 

2.4 

 

 

 

(6,406)

 

(20.0)

 

 

 

12,964 

 

8.8 

 

Revenue – 1st quarter 2015

 

$

86,262 

 

53.7 

%

 

$

48,704 

 

30.3 

%

 

$

25,756 

 

16.0 

%

 

$

160,722 

 

100 

%

 

Revenue from operations in the Americas for the first quarter of 2015 increased by $18.3 million, or 26.8%, to $86.3 million from $68.0 million in the first quarter of 2014. The increase was due to higher volume and the favorable combined effect of price and mix, partially offset by an unfavorable impact of foreign currency translation from Latin America.

 

Revenue from operations outside the Americas in the first quarter of 2015 decreased by $5.2 million, or 6.6%, to $74.5 million from $79.7 million in the first quarter of 2014. Revenue from operations outside the Americas as a percent of total revenue was 46.3% and 54.0%, at March 31, 2015 and 2014, respectively. Excluding the effect of foreign currency translation on revenues outside the U.S. would result in 16.7% growth for the first quarter of 2015 compared to  71.9% growth in the first quarter of 2014.

 

Revenue from operations in EMEA in the first quarter of 2015 increased by $1.1 million, or 2.4%, to $48.7 million from $47.6 million in the first quarter of 2014. This increase was due to a favorable combined effect of price and mix, partially offset by an unfavorable impact of foreign currency translation and lower volume.

 

Revenue from Asia Pacific operations in the first quarter of 2015 decreased by $6.4 million, or 20.0%, to $25.8 million from $32.2 million in the first quarter of 2014, due primarily to a decrease in volume and an unfavorable effect of foreign currency translation, partially offset by the favorable combined effect of price and mix.

 

Gross profit and gross profit margins

 

Table 3 sets forth gross profit and gross profit margins for our products and services for the first quarters of 2015 and 2014:

 

Table 3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quarter Ended March 31,

 

2015

 

2014

(Dollars in thousands)

Gross Profit

 

Gross Profit Margin

 

Gross Profit

 

Gross Profit Margin

Products

$

21,764 

 

34.7 

%

 

$

24,162 

 

39.8 

%

Materials

 

27,582 

 

74.3 

 

 

 

30,216 

 

74.7 

 

Services

 

29,638 

 

48.7 

 

 

 

21,094 

 

45.3 

 

Total

$

78,984 

 

49.1 

%

 

$

75,472 

 

51.1 

%

 

On a consolidated basis, gross profit for the first quarter of 2015 increased by $3.5 million to $79.0 million from $75.5 million in the first quarter of 2014, primarily as a result of higher revenue from services.

 

Consolidated gross profit margin in the first quarter of 2015 decreased by 2.0 percentage points to 49.1% from 51.1% for the first quarter of 2014.  The lower gross profit margin reflects a change in revenue mix with a higher portion of revenue from lower margin products within categories.

20

 


 

 

 

Products gross profit for the first quarter of 2015 decreased by $2.4 million, or 9.9%, to $21.8 million from $24.2 million in the 2014 quarter. Gross profit margin for products decreased by 5.1 percentage points to 34.7% from 39.8% in the 2014 quarter.  Despite the addition of higher margin healthcare products and increasing software contribution, gross profit margin decreased due to mix of products, including a higher portion of sales from consumer products, coupled with continued expansion of our manufacturing capacity.

 

Materials gross profit for the first quarter of 2015 decreased by $2.6 million, or 8.7%, to $27.6 million from $30.2 million in the 2014 quarter, and gross profit margin for materials decreased by 0.4 percentage points to 74.3% from 74.7% in the 2014 quarter primarily due to the volume and mix of materials sold during the quarter.

 

Gross profit for services for the first quarter of 2015 increased by $8.5 million, or 40.5%, to $29.6 million from $21.1 million in the  2014 quarter. Gross profit margin for services increased by 3.4 percentage points to 48.7% from 45.3% in the 2014 quarter. The increase in gross profit margin for services was primarily due to the addition of higher margin healthcare services and an increase in Quickparts gross profit margin, to 44.4% for the first quarter of 2015 from 41.5% in the first quarter of 2014.

 

Operating expenses

 

As shown in Table 4, total operating expenses increased by $30.5 million, or 46.3%, to $96.5 million in the first quarter of 2015 from $66.0 million in the first quarter of 2014. This increase was due to higher selling, general and administrative expenses and higher research and development expenses, both of which are discussed below.

 

Table 4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quarter Ended March 31,

 

2015

 

2014

(Dollars in thousands)

Amount

 

% Revenue

 

Amount

 

% Revenue

Selling, general and administrative expenses

$

74,292 

 

46.2 

%

 

$

48,720 

 

33.0 

%

Research and development expenses

 

22,216 

 

13.8 

 

 

 

17,235 

 

11.7 

 

Total operating expenses

$

96,508 

 

60.0 

%

 

$

65,955 

 

44.7 

%

 

Selling, general and administrative expenses increased by $25.6 million to $74.3 million in the first quarter of 2015 compared to $48.7 million in the first quarter of 2014, and increased to 46.2% of revenue in 2015 compared to 33.0% for 2014. The increase was due primarily to an $11.0 million increase in compensation costs due to increased staffing, a $5.3 million increase in amortization, a $1.5 million increase in bad debt expense, a $1.2 million increase in marketing expenses and a $1.1 million increase in legal fees related to acquisitions.

 

Research and development expenses increased by $5.0 million, or 28.9%, to $22.2 million in the first quarter of 2015 from $17.2 million in the first quarter of 2014. This increase was primarily due to a $3.0 million increase in compensation expenses related to talent expansion and a $1.7 million increase in consulting fees.

 

Income (loss) from operations

 

Our loss from operations of $17.5 million for the first quarter of 2015 decreased from income from operations of $9.5 million in the first quarter of 2014. See Gross profit and gross profit margins and Operating expenses above. The following table sets forth operating income by geographic area for the first quarter of 2015 compared to 2014:

 

Table 5

 

 

 

 

 

 

 

 

 

 

 

 

 

Quarter Ended March 31,

(Dollars in thousands)

2015

 

2014

Income (loss) from operations

 

 

 

 

 

Americas

$

(23,106)

 

$

(2,030)

Germany

 

1,840 

 

 

197 

Other EMEA

 

(1,335)

 

 

2,401 

Asia Pacific

 

5,584 

 

 

9,067 

Subtotal

 

(17,017)

 

 

9,635 

Inter-segment elimination

 

(507)

 

 

(118)

Total

$

(17,524)

 

$

9,517 

21

 


 

 

 

With respect to the Americas, in 2015 and 2014, the changes in operating income by geographic area reflected the same factors relating to our consolidated operating income that are discussed above.

 

The changes in operating income in our operations outside the Americas in 2015 and 2014 resulted primarily from changes in sales volume, transfer pricing and foreign currency translation.

 

Interest and other expense, net

 

Interest and other expense, net was $2.6 million in the first quarter of 2015 compared with $1.0 million in the 2014 quarter. For the first quarter of 2015, interest and other expense, net, primarily consisted of $2.2 million of foreign exchange loss, $0.3 million of other expense and $0.2 million of interest expense; partially offset by $0.1 million of interest and other income. 

 

For the first quarter of 2014, interest and other expense, net, primarily consisted of $0.6 million of other expense, $0.4 million of interest expense and a foreign exchange loss of $0.2 million, partially offset by $0.2 million of interest and other income.

 

Benefit and provision for income taxes

 

We recorded a $6.9 million benefit for income taxes in the first quarter of 2015 and a $3.6 million provision for income taxes in the first quarter of 2014. Our 2015 and 2014 benefit and provision for income taxes reflects income taxes in U.S. and non-U.S. jurisdictions.  

 

Net income (loss)

 

Net loss attributable to the Company for the first quarter of 2015 was $13.2 million, compared to net income of $4.9 million in the first quarter of 2014. The principal reasons for the change, which are discussed in more detail above, were:

 

• the $27.0 million decrease in operating income and

 

• the $1.5 million increase in interest and other expense; partially offset by

 

• the $10.5 million decrease in our tax provision.

 

For the quarter ended March 31, 2015, average common shares for basic and diluted loss per share was 111.7 million and  basic and diluted loss per share was $0.12. For the quarter ended March 31, 2014, average common shares for basic and diluted earnings per share was 103.5 million and basic and diluted earnings per share was $0.05.

 

Other Financial Information

 

In addition to our results determined under U.S. generally accepted accounting principles (“GAAP”) discussed above, management believes  non-GAAP financial measures, which adjust net income and earnings per share are useful to investors in evaluating our operating performance.

 

We use non-GAAP financial measures of adjusted net income and adjusted earnings per share to supplement our unaudited condensed consolidated financial statements presented on a GAAP basis to facilitate a better understanding of the impact that several strategic acquisitions had on our financial results.

 

These non-GAAP financial measures have not been prepared in accordance with GAAP and may be different from non-GAAP financial measures used by other companies and they are subject to inherent limitations as they reflect the exercise of judgments by our management about which costs, expenses and other items are excluded from our GAAP financial statements in determining our non-GAAP financial measures. We have sought to compensate for these limitations by analyzing current and expected future results on a GAAP basis as well as a non-GAAP basis and also by providing GAAP financial statements as required in our public disclosures as well as reconciliations of our non-GAAP financial measures of adjusted net income and adjusted earnings per share to our GAAP financial statements.

 

The presentation of our non-GAAP financial measures which adjust net income and earnings per share are not meant to be considered in isolation or as a substitute for the directly comparable financial measures prepared in accordance with GAAP. These non-GAAP financial measures are meant to supplement, and be viewed in conjunction with, GAAP financial measures. We urge investors to review the reconciliation of our non-GAAP financial measures to the comparable GAAP financial measures included below, and not to rely on any single financial measure to evaluate our business.

22

 


 

 

 

Our non-GAAP financial measures, which adjust net income and earnings per share, are adjusted for the following:

 

·

Non-cash stock-based compensation expenses.  We exclude the tax-effected stock-based compensation expenses from operating expenses primarily because they are non-cash.

 

·

Amortization of intangibles.  We exclude the tax-effected amortization of intangible assets from our cost of sales and operating expenses. The increase in recent periods is primarily in connection with acquisitions of businesses.

 

·

Acquisition and severance expenses.  We exclude the tax-effected charges associated with the acquisition of businesses and the related severance expenses from our operating expenses.

 

·

Non-cash interest expense. We exclude tax-effected non-cash interest expenses, primarily related to the costs associated with our senior convertible notes, from interest and other expenses, net.  

 

Reconciliation of GAAP Net Income to Non-GAAP Financial Measures

Table 6

 

 

 

 

 

 

 

 

 

 

 

 

 

Quarter Ended March 31,

(in thousands, except per share amounts)

 

2015

 

2014

GAAP net income (loss) attributable to 3D Systems Corporation

 

$

(13,181)

 

 

$

4,877 

Cost of sales adjustments:

 

 

 

 

 

 

 

Amortization of intangibles

 

 

75 

 

 

 

65 

Operating expense adjustments:

 

 

 

 

 

 

 

Amortization of intangibles

 

 

14,441 

 

 

 

9,128 

Acquisition and severance expenses 

 

 

3,240 

 

 

 

990 

Non-cash stock-based compensation expense

 

 

10,329 

 

 

 

7,276 

Interest and other expense adjustments:

 

 

 

 

 

 

 

Non-cash interest expense

 

 

 

 

 

96 

Tax effect (a)

 

 

(9,705)

 

 

 

(7,373)

Non-GAAP net income

 

$

5,199 

 

 

$

15,059 

 

 

 

 

 

 

 

 

Non-GAAP basic and diluted earnings per share

 

$

0.05 

 

 

$

0.15 

 

a) Tax effect is calculated quarterly, based on the actual tax rate for each quarter.

 

Financial Condition and Liquidity

 

Table 7

 

 

 

 

 

 

 

 

 

 

 

 

(Dollars in thousands)

 

March 31, 2015

 

December 31, 2014

Cash and cash equivalents

 

$

199,896 

 

$

284,862 

Working capital

 

$

348,234 

 

$

432,199 

Stockholders' equity attributable to 3D Systems Corporation

 

$

1,270,306 

 

$

1,292,918 

 

Our unrestricted cash and cash equivalents decreased by $85.0 million to $199.9 million at March 31, 2015 from $284.9 million at December 31, 2014. We used $0.9 million of cash from operating activities. Cash from operations consisted of $13.1 million of net loss, $22.7 million of non-cash charges and $10.5 million of cash used by net changes in operating accounts. We used $82.5 million of cash in investing activities, including $78.6 million to fund the acquisition of Cimatron and other investing activities. Cash from financing activities provided $0.6 million of cash.  See Cash flow and Capitalized lease obligations below. 

 

Cash and cash equivalents at March 31, 2015 includes $51.2 million of cash held outside the U.S., compared to $39.6 million at December 31, 2014. Cash held outside the U.S. is used in our foreign operations for working capital purposes and is considered to be permanently invested; consequently, we have not provided for any taxes on repatriation. The increase in cash held outside the U.S. is primarily attributable to the Cimatron acquisition.

23

 


 

 

 

Cash equivalents comprise funds held in money market instruments and are reported at their current carrying values, which approximate fair value due to the short-term nature of these instruments. We minimize our credit risk by investing primarily in investment grade, liquid instruments and limit exposure to any one issuer depending on credit quality.

 

Our net working capital decreased by $84.0 million to $348.2 million at March 31, 2015 from $432.2 million at December 31, 2014, primarily due to the factors discussed below.

 

Accounts receivable, net, decreased by $15.3 million to $153.1 million at March 31, 2015 from $168.4 million at December 31, 2014. Gross accounts receivable decreased by $12.4 million from December 31, 2014. Days sales outstanding was 86 days at March 31, 2015 compared to 83 days at December 31, 2014. Accounts receivable more than 90 days past due decreased to 14.9% of gross receivables from 16.7% at December 31, 2014. 

 

Inventories, net increased by $18.0 million to $114.6 million at March 31, 2015 from $96.6 million at December 31, 2014. This increase resulted primarily from an expanding product portfolio, acquired inventory, timing of orders, assembly production, and sales and revenue recognition at quarter-end. The increase in inventory reflects a $7.6 million increase in raw materials inventory and a $10.3 million increase in finished goods inventory.  We maintained $7.4 million of inventory reserves at March 31, 2015 and $6.7 million of such reserves at December 31, 2014.    

 

The majority of our inventory consists of finished goods, including products, materials and service parts. Inventory also consists of raw materials and spare parts for the in-house assembly and support service products. We outsource the assembly and refurbishment of certain production printers; therefore, we generally do not hold in inventory most parts for production printer assembly or refurbishment. 

 

The changes in the first quarter of 2015 that make up the other components of working capital not discussed above arose in the ordinary course of business.

 

Differences between the amounts of working capital item changes in the cash flow statement and the balance sheet changes for the corresponding items are primarily the result of foreign currency translation adjustments.

 

We have relied on our unrestricted cash,  cash flow from operations and capital markets transactions to meet our cash requirements for working capital, capital expenditures and acquisitions; however, it is possible that we may need to raise additional funds to finance our activities beyond the next twelve months or to consummate significant acquisitions of other businesses, assets, products or technologies.  If needed, we may be able to raise such funds by issuing equity or debt securities to the public or selected investors, or by borrowing from financial institutions, selling assets or restructuring debt

 

Cash flow

 

The table below summarizes the cash provided by or used in operating activities, investing activities and financing activities, as well as the effect of changes in foreign currency exchange rates on cash, for the first quarter of 2015 and 2014.

 

Table 8

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

 

 

2015

 

2014

(Dollars in thousands)

 

 

 

 

 

 

Cash provided by (used in) operating activities

 

$

(937)

 

$

308 

Cash used in investing activities

 

 

(82,480)

 

 

(5,861)

Cash provided by financing activities

 

 

631 

 

 

5,888 

Effect of exchange rate changes on cash

 

 

(2,180)

 

 

53 

Net increase (decrease) in cash and cash equivalents

 

$

(84,966)

 

$

388 

 

Cash flow from operating activities

 

For the quarter ended March 31, 2015, our operating activities used $0.9 million of net cash. This use of cash consisted primarily of net loss plus the effects of non-cash items and changes in working capital, which are described above. Our cash from operations fluctuates from quarter to quarter due to the timing of transactions and receipts and payments of cash.

24

 


 

 

 

For the quarter ended March 31, 2014, our operating activities provided $0.3 million of net cash. This source of cash consisted primarily of net income plus the effects of non-cash items and changes in working capital.

 

Cash flow from investing activities

 

Net cash used in investing activities for the first quarter of 2015 increased to $82.5 million from $5.9 million for the first quarter of 2014. This increase was primarily due to $78.0 million of cash paid for the acquisition of Cimatron in the first quarter of 2015 compared to $2.0 million paid for acquisitions in the 2014 quarter. Cash flow used in investing activities also includes minority investments of less than 20% made through 3D Ventures, our venture investment initiative, in promising enterprises that we believe will benefit from or be powered by our technologies. During the first quarter of 2015,  we invested $0.6 million in these enterprises and ventures, compared to $0.1 million in the first quarter of 2014.

 

Cash flow from financing activities

 

Financing activities provided net cash of $0.6 million for the quarter ended March 31, 2015 compared to $5.9 million in the 2014 period. Cash from financing activities for the first quarter of 2015 primarily included $0.4 million of tax benefits from share-based payment arrangements. Cash from financing activities for the first quarter of 2014 was primarily from $5.4 million of tax benefits from share-based payment arrangements. 

 

Contractual commitments and off-balance sheet arrangements

 

Credit facilities

 

In October 2014, we entered into a $150.0 million five-year revolving, unsecured credit facility with PNC Bank, as Administrative Agent, and certain other lenders. The agreement provides for advances in the initial aggregate principal amount of up to $150.0 million. Subject to certain terms and conditions contained in the agreement, the Company may, at its option and subject to customary conditions, request an increase in the aggregate principal amount available under the credit facility by an additional $75.0 million. As of March 31, 2015 and December 31, 2014, there was no outstanding balance on the credit facility.

 

Capitalized lease obligations

 

Our capitalized lease obligations include lease agreements that we entered into during 2006 with respect to our Rock Hill facility and lease agreements assumed in the LayerWise acquisition. Our total capitalized lease obligations decreased to $9.1 million at March 31, 2015 from $9.4 million at December 31, 2014 primarily due to the normal scheduled timing of payments. Our outstanding capitalized lease obligations carrying values at March 31, 2015 and December 31, 2014 were as follows:

 

Table 9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Dollars in thousands)

 

March 31, 2015

 

December  31, 2014

Capitalized lease obligations:

 

 

 

 

 

 

Current portion of capitalized lease obligations

 

$

497 

 

$

529 

Capitalized lease obligations, long-term portion

 

 

8,581 

 

 

8,905 

Total capitalized lease obligations

 

$

9,078 

 

$

9,434 

 

Other debt

 

In connection with our acquisition of LayerWise, we assumed a portion of LayerWise’s outstanding bank debt, consisting of revolving credit facilities and term loans. The term loans bear interest at rates ranging from 1.34% to 5.40% as of March 31, 2015. The outstanding balance on the term loans was $0.1 million at March 31, 2015 and December 31, 2014. There were no borrowings outstanding under the revolving credit facilities as of March 31, 2015 or December 31, 2014.

 

Other contractual arrangements

 

Certain of our recent acquisitions contain earnout provisions under which the sellers of the acquired businesses can earn additional amounts. The total amount of liabilities recorded for these earnouts at March 31, 2015 and December 31, 2014 was $9.2 million.

 

As of March 31, 2015, we have supply commitments related to printer assemblies that total $77.6 million compared to $56.6 million at December 31, 2014.

25

 


 

 

 

The minority interest shareholders of a certain subsidiary have the right to require the Company to acquire their ownership interest under certain circumstances pursuant to a contractual arrangement and the Company has a similar call option under the same contractual terms. The amount of consideration under the put and call rights is not a fixed amount, but rather is dependent upon various valuation formulas and on future events, such as revenue and gross margin performance of the subsidiary through the date of exercise, as described in Note 15.  Management estimates, assuming that the subsidiary owned by the Company at March 31, 2015, performs over the relevant future periods at their forecasted earnings levels, that these rights, if exercised, could require the Company, in future periods, to pay approximately $8.8 million to the owners of such rights to acquire such ownership interests in the relevant subsidiary. This amount has been recorded as redeemable noncontrolling interests on the balance sheet at March 31, 2015.

 

Off-balance sheet arrangements

 

We have no off-balance sheet arrangements and do not utilize any “structured debt,” “special purpose,” or similar unconsolidated entities for liquidity or financing purposes.

 

Financial instruments

 

We conduct business in various countries using both the functional currencies of those countries and other currencies to effect cross border transactions. As a result, we are subject to the risk that fluctuations in foreign exchange rates between the dates that those transactions are entered into and their respective settlement dates will result in a foreign exchange gain or loss. When practicable, we endeavor to match assets and liabilities in the same currency on our balance sheet and those of our subsidiaries in order to reduce these risks. We also, when we consider it to be appropriate, enter into foreign currency contracts to hedge exposures arising from those transactions.

 

We do not hedge or trade for speculative purposes, and our foreign currency contracts are generally short-term in nature, typically maturing in 90 days or less.  We have elected not to prepare and maintain the documentation to qualify for hedge accounting treatment under ASC 815, “Derivatives and Hedging,” and therefore, we recognize all gains and losses (realized or unrealized) in interest and other expense, net in our unaudited condensed consolidated statements of operations and comprehensive income (loss).

 

There were no foreign exchange contracts at March 31, 2015 or December 31, 2014. See Note 7 of the unaudited condensed consolidated financial statements.

 

Changes in the fair value of derivatives are recorded in interest and other expense, net, in our unaudited condensed consolidated statements of operations and comprehensive income. Depending on their fair value at the end of the reporting period, derivatives are recorded either in prepaid and other current assets or in accrued liabilities in our unaudited condensed consolidated balance sheets.

 

Recent Accounting Pronouncements

 

For information with respect to recent accounting pronouncements and the impact of these pronouncements on our unaudited condensed consolidated financial statements, see Note 1 to the unaudited condensed consolidated financial statements.

 

Critical Accounting Policies and Significant Estimates

 

For a discussion of our critical accounting policies and estimates, refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Significant Estimates” in our Annual Report on Form 10-K for the year ended December 31, 2014.

26

 


 

 

 

Forward-Looking Statements

 

Certain statements made in this Form 10-Q that are not statements of historical or current facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include the cautionary statements and risk factors set forth below and in our Form 10-K for the year ended December 31, 2014, as well as other statements made in this Form 10-Q that may involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from historical results or from any future results expressed or implied by such forward-looking statements.

 

In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements in future or conditional tenses or that include terms such as “believes,” “belief,” “expects,” “estimates”, “intends,” “anticipates” or “plans” to be uncertain and forward-looking. Forward-looking statements may include comments as to our beliefs, expectations and projections as to future events and trends affecting our business. Forward-looking statements are based upon management’s beliefs, assumptions and current expectations concerning future events and trends, using information currently available, and are necessarily subject to uncertainties, many of which are outside of our control. The factors stated under the heading “Cautionary Statements and Risk Factors” set forth below and those described in our other SEC reports, including our Form 10-K for the year ended December 31, 2014, as well as other factors, could cause actual results to differ materially from those reflected or predicted in forward-looking statements.

 

Forward looking statements are not, and should not be relied upon as a guarantee of future performance or results, nor will they necessarily prove to be accurate indications of the times at or by which any such performance or results will be achieved. We undertake no obligation and do not intend to update or revise any forward-looking statements, except as may be required by law.

 

Any forward-looking statement you read in this Form 10-Q reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. All subsequent written and oral forward-looking statements attributable to us or individuals acting on our behalf are expressly qualified in their entirety by the paragraphs under the headings “Forward-Looking Statements” and “Cautionary Statements and Risk Factors” in this Form 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hearof. You should specifically consider the factors identified or referred to in this Form 10-Q and our other SEC reports, including our Form 10-K for the year ended December 31, 2014, which would cause actual results to differ from those referred to in forward-looking statements.

 

Cautionary Statements and Risk Factors

 

We recognize that we are subject to a number of risks and uncertainties that may affect our future performance. The risks and uncertainties described in Item 1A in our Form 10-K for the year ended December 31, 2014 are not the only risks and uncertainties that we face. Additional risks and uncertainties not currently known to us or that we currently deem not to be material also may impair our business, results of operations and financial condition. If any of these risks actually occur, our business, results of operations and financial condition could be materially adversely affected. In that event the trading price of our common stock could decline, and you may lose all or part of your investment in our common stock. The risks discussed in Item 1A in our Form 10-K for the year ended December 31, 2014 also include forward-looking statements, and our actual results may differ substantially from those discussed in these forward-looking statements.

 

Except as required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

 

Item 3.  Quantitative and Qualitative Disclosures About Market Risk.

 

For a discussion of market risks at December 31, 2014, refer to Item 7A, “Quantitative and Qualitative Disclosures about Market Risk,” in our Form 10-K for the year ended December 31, 2014. During the first quarter of 2015, there were no material changes or developments that would materially alter the market risk assessment performed as of December 31, 2014.

27

 


 

 

 

Item 4.  Controls and Procedures.

 

Evaluation of disclosure controls and procedures

 

As of March 31, 2015, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) pursuant to Rules 13a-15 and 15d-15 under the Exchange Act. These controls and procedures were designed to provide reasonable assurance that the information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, in a manner to allow timely decisions regarding required disclosures. Based on this evaluation, including an evaluation of the rules referred to above in this Item 4, management has concluded that our disclosure controls and procedures were effective as of March 31, 2015 to provide reasonable assurance that the information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, in a manner to allow timely decisions regarding required disclosures.

 

Changes in Internal Controls over Financial Reporting

 

There were no material changes in our internal controls over financial reporting during the period covered by this Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

28

 


 

 

 

 

PART II — OTHER INFORMATION

 

Item 1.  Legal Proceedings.

 

The information set forth in Note 15 of the unaudited condensed consolidated financial statements in Part I, Item 1 of this Form 10-Q is incorporated herein by reference.

 

Item 1A.  Risk Factors.

 

There have been no material changes from the risk factors as previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2014.

 

Item 6.  Exhibits.

 

The following exhibits are included as part of this filing and incorporated herein by this reference:

 

 

 

 

3.1

Certificate of Incorporation of Registrant. (Incorporated by reference to Exhibit 3.1 to Form 8-B filed on August 16, 1993, and the amendment thereto, filed on Form 8-B/A on February 4, 1994.)

 

 

3.2

Amendment to Certificate of Incorporation filed on May 23, 1995. (Incorporated by reference to Exhibit 3.2 to Registrant’s Registration Statement on Form S-2/A, filed on May 25, 1995.)

 

 

3.3

Certificate of Designation of Rights, Preferences and Privileges of Preferred Stock. (Incorporated by reference to Exhibit 2 to Registrant’s Registration Statement on Form 8-A filed on January 8, 1996.)

 

 

3.4

Certificate of Designation of the Series B Convertible Preferred Stock, filed with the Secretary of State of Delaware on May 2, 2003. (Incorporated by reference to Exhibit 3.1 to Registrant’s Current Report on Form 8-K, filed on May 7, 2003.)

 

 

3.5

Certificate of Elimination of Series A Preferred Stock filed with the Secretary of State of Delaware on March 4, 2004. (Incorporated by reference to Exhibit 3.6 of Registrant’s Annual Report on Form 10-K for the year ended December 31, 2003, filed on March 15, 2004.)

 

 

3.6

Certificate of Elimination of Series B Preferred Stock filed with the Secretary of State of Delaware on September 9, 2006. (Incorporated by reference to Exhibit 3.1 of Registrant’s Current Report on Form 8-K, filed on September 9, 2006.)

 

 

3.7

Certificate of Amendment of Certificate of Incorporation filed with Secretary of State of Delaware on May 19, 2004. (Incorporated by reference to Exhibit 3.1 of the Registrant’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2004, filed on August 5, 2004.)

 

 

3.8

Certificate of Amendment of Certificate of Incorporation filed with Secretary of State of Delaware on May 17, 2005. (Incorporated by reference to Exhibit 3.1 of the Registrant’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2005, filed on August 1, 2005.)

 

 

3.9

Certificate of Amendment of Certificate of Incorporation filed with the Secretary of State of Delaware on October 7, 2011.  (Incorporated by reference to Exhibit 3.1 to Form 8-K filed on October 7, 2011.)

 

 

3.10

Certificate of Designations, Preferences and Rights of Series A Preferred Stock, filed with the Secretary of State of Delaware on December 9, 2008. (Incorporated by reference to Exhibit 3.1 of Registrant’s Current Report on Form 8-K, filed on December 9, 2008.)

 

 

3. 11

Certificate of Elimination of Series A Preferred Stock, filed with the Secretary of State of Delaware on November 14, 2013. (Incorporated by reference to Exhibit 3.1 of Registrant’s Current Report on Form 8-K, filed on November 15, 2013.)

 

 

29

 


 

 

 

 

 

3.12

Amended and Restated By-Laws of 3D Systems Corporation (as adopted February 16, 2015). (Incorporated by reference to Exhibit 3.1 of Registrant’s Current Report on Form 8-K filed on February 17, 2015.)

 

 

3.13

Certificate of Amendment of Certificate of Incorporation filed with the Secretary of State of Delaware on May 21, 2013. (Incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K, filed on May 22, 2013.)

 

 

10.1

Appendix A to the Amended and Restated Incentive Stock Plan of 3D Systems Corporation effective March 11, 2015.

 

 

10.2

Amended and Restated 2004 Incentive Stock Plan of 3D Systems Corporation (Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed February 5, 2015.)

 

 

10.3

Form of Restricted Stock Purchase Agreement. (Incorporated by reference to Exhibit 10.3 to the Registrant’s Current Report on Form 8-K, filed on February 5, 2015.)

 

 

10.4

Form of Restricted Stock Unit Purchase Agreement. (Incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K, filed on February 5, 2015.)

 

 

31.1

Certification of Principal Executive Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 dated May 6, 2015.

 

 

31.2

Certification of Principal Financial Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 dated May 6, 2015.

 

 

32.1

Certification of Principal Executive Officer filed pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 dated May 6, 2015.

 

 

32.2

Certification of Principal Financial Officer filed pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 dated May 6, 2015.

 

 

101.INS

XBRL Instance Document.

 

 

101.SCH

XBRL Taxonomy Extension Schema Document.

 

 

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document.

 

 

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document.

 

 

101.LAB

XBRL Taxonomy Extension Label Linkbase Document.

 

 

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document.

30

 


 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

 

 

 

 

3D Systems Corporation

 

 

 

 

By

/s/ Theodore A. Hull

 

 

Theodore A. Hull

 

 

Executive Vice President and Chief Financial Officer

 

 

(principal financial  officer)

 

 

(duly authorized officer)

 

 

 

 

Date: May 6, 2015

 

31

 


EXHIBIT 10.1

3D SYSTEMS Corporation

Appendix A to the Amended and Restated 2004 Incentive Stock Plan

 

This Appendix A  (Israeli Appendix) to the 3D Systems Corporation Amended and Restated 2004  Stock Incentive Stock Plan (the Plan) is hereby established effective as of March 11, 2015.

 

1.

Definitions

As used herein, the following terms shall have the meanings hereinafter set forth, unless the context clearly indicates to the contrary. Any capitalized term used herein which is not specifically defined in this Israeli Appendix shall have the meaning set forth in the Plan.

 

1.1

Affiliate  – for purposes of eligibility under the Israeli Appendix shall have the meaning of the term in the Plan, provided however that any affiliated entity shall be an employing company within the meaning of such term in Section 102 of the Ordinance.

 

1.2

Affiliated Companyeither an Affiliate or a Subsidiary.

 

1.3

Election – the election by the Company, with respect to grant of 102 Trustee Awards, of either one of the following tax tracks – Capital Gains Tax Track or Ordinary Income Tax Track, as provided in and in accordance with the Section 102.

 

1.4

Exercised Stock – (i) shares of Common Stock purchased pursuant to the exercise of a Stock Option; and/or (ii) any shares of Common Stock issued by the Company pursuant to Section 7(e)(ii) to the Plan.

 

1.5

Fair Market Value  solely for the purposes of 102 Trustee Awards, if and to the extent Section 102 prescribes a specific mechanism for determining the Fair Market Value of any Common Stock issued in connection with an Award, then notwithstanding the definition in the Plan, the Fair Market Value of 102 Trustee Awards shall be as prescribed in Section 102, if applicable.

 

1.6

102 Non-Trustee Award – an Award granted not through a Trustee in accordance with and pursuant to Section 102.

 

1.7

3(i) Award – an Award granted pursuant to Section 3(i) of the Ordinance.

 

1.8

Award  – a grant of an Option or Restricted Stock Unit.

 

1.9

Ordinance  the Israeli Income Tax Ordinance [New Version], 1961, and the rules and regulations promulgated thereunder, as are in effect from time to time, and any similar successor rules and regulations.

 

1.10

Restricted Period – as defined in Section 4.3 hereinbelow.

 

1.11

Section 102 – Section 102 of the Ordinance and the rules and regulations promulgated thereunder, as are in effect from time to time, and any similar successor rules and regulations.

 

1.12

Subsidiary  for purposes of eligibility under the Israeli Appendix shall have the meaning of the term in the Plan, provided however that any affiliated entity shall be an employing company within the meaning of such term in Section 102 of the Ordinance.

 

1.13

Trustee  the trustee designated or replaced by the Company and/or applicable Affiliated Company for the purposes of the Plan and approved by the Israeli Tax Authorities all in accordance with the provisions of Section 102.

 

1.14

102 Trustee Award – an Award granted through a Trustee in accordance with and pursuant to Section 102.

 

 

253304/1


 

 

 

1.15

102 Trustee Option – an Option granted through a Trustee in accordance with and pursuant to Section 102.

 

2.

General

2.1

The purpose of this Israeli Appendix is to establish certain rules and limitations applicable to Awards granted to Participants, the grant of Awards to whom (or, as applicable, the exercise thereof by whom) are subject to taxation by the Israeli Income Tax (Israeli Participants), in order that such Awards may comply with the requirements of Israeli law, including, if applicable, Section 102.

 

2.2

The Plan and this Israeli Appendix are complementary to each other and shall be read and deemed as one. In the event of any contradiction, whether explicit or implied, between the provisions of this Israeli Appendix and the Plan, the provisions of this Israeli Appendix shall prevail with respect to Awards granted to Israeli Participants.

 

2.3

Awards may be granted under this Israeli Appendix in one of the following tax tracks, at the Companys discretion and subject to applicable restrictions or limitations as provided in applicable law including without limitation any applicable restrictions and limitations in Section 102 regarding the eligibility of Israeli Participants to each of the following tax tracks, based on their capacity and relationship towards the Company:

 

(i) 102 Trustee Awards- in such tax track as determined in accordance with the Election; or

 

(ii) 102 Non-Trustee Awards; or

 

(iii) 3(i) Awards.

 

For avoidance of doubt, the designation of the Awards to any of the above tax tracks shall be subject to the terms and conditions set forth in Section 102.

 

3.

Administration

Without derogating from the powers and authorities of the Board detailed in the Plan, the Board and/or the Committee shall have the sole and full discretion and authority, without the need to submit its determinations or actions to the stockholders of the Company for their approval or authorization, unless such approval is required to comply with applicable law, to administer this Israeli Appendix and to take all actions related hereto and to such administration, including without limitation the performance, from time to time and at any time, of any and all of the following:

 

(a)

the determination of the specific tax track (as described in Section 2.3 above) in which the Awards are to be issued.

 

(b)

the Election;

 

(c)

the appointment of the Trustee

 

(d)

the adoption of forms of Award Agreements to be applied with respect to Israeli Participants (the “Israeli Award Agreement”), incorporating and reflecting, inter alia, relevant provisions regarding the grant of Awards in accordance with this Israeli Appendix, and the amendment or modification from time to time of the terms of such Israeli Award Agreements.

 

4.

102 Trustee Awards

4.1

Grant in the Name of Trustee:

Notwithstanding anything to the contrary in the Plan, 102 Trustee Awards granted hereunder shall be granted to, and any Exercised Stock shall be issued to, and all rights attached to the 102 Trustee Awards (including bonus shares) shall be issued to, the Trustee, and all such options and shares shall be registered in the name of the Trustee, who shall hold them in trust until such time as they are

 

2

 


 

 

released by the transfer or sale thereof by the Trustee. In case the requirements of Section 102 for 102 Trustee Awards are not met, then the 102 Trustee Awards may be regarded as 102 Non-Trustee Awards, all in accordance with the provisions of Section 102. Notwithstanding anything to the contrary in the Plan, the Date of Grant of a 102 Trustee Award shall be the date determined by the Board and/or the Committee to be the effective date of the grant of the 102 Trustee Awards to an Israeli Participant, or, if the Board and/or the Committee have not determined such effective date, the date of the resolution of the Board and/or the Committee approving the grant of such Awards, which in the case of 102 Trustee Awards shall not be before the lapse of 30 days (or such other period which may be determined by the Ordinance from time to time) from the date upon which the Plan is first submitted to the relevant Israeli Tax Authorities.

 

4.2

Exercise of Vested 102 Trustee Options and applicable actions in respect to Restricted Stock Units:

4.2.1

(a)

Unless other procedures shall be determined from time to time by the Board and/or the Committee and notified to the Israeli Participants, the mechanism of exercising vested 102 Trustee Options shall be in accordance with the provisions of the Plan, except that any notice of exercise of 102 Trustee Options shall be made in such form and method in compliance with the provisions of Section 102 and shall also be delivered in copy to the authorized representative of the Affiliated Company with which the Israeli Participant is employed and/or engaged, if applicable, and to the Trustee.

 

(b)

In order to exercise the 102 Trustee Options, the Participant shall deliver to the Trustee, a notice of exercise, in a form as shall be determined by the Trustee, and that will be available at the Companys principal offices until the expiration of the Stock Options. The Participant shall specify in the notice of exercise the amount of Stock Options that he/she wishes to exercise and his/her election of one of the following alternatives:

 

i.

Exercise of the Options where the Exercised Stock shall be held by the Trustee for the Participant, in a trust account that shall be opened by the Trustee for the Participant;

ii.

Exercise of the Options and sale of the Exercised Stock by the Trustee for the Participant, whether in whole or in part, as shall be determined by the Participant, provided, however, that there is no legal hindrance with respect to the sale of the Exercised Stock (restriction provisions);

iii.

Exercise of the Options and transfer of the Exercised Stock, that shall be registered in the name of the relevant registration company of a bank (the Registration Company), to the Participants bank account; and

(c)

The Trustee shall verify with the Company the eligibility of the Participant to take such actions and shall act as aforesaid, subject to receipt of a written approval by the Company that the Participant is entitled to exercise the Options or exercise the Options and sell the Exercised Stock or exercise the Options and release the Exercised Stock, as the case may be.

 

4.2.2     Upon the lapse of the restrictions applicable to the Restricted Stock Units pursuant to the Plan, should the Company elect to issue any Common Stock as per Section 7(e)(ii) to the Plan, the Participant may elect to take any of the following actions, and shall deliver to the Trustee a notice with respect to his/her election with respect thereto (with a copy to the Company and to the authorized representative of the Affiliated Company with which the Israeli Participant is employed and/or engaged, if applicable):

i.

The sale of the Exercised Stock by the Trustee for the Participant, whether in whole or in part, as shall be determined by the Participant, provided, however, that there is no legal hindrance with respect to the sale of the Exercised Stock (restriction provisions); and

ii.

The transfer by the Trustee of the Exercised Stock, that shall be registered in the name of the relevant Registration Company to the Participants bank account.

 

3

 


 

 

4.2.3

(a)

(i) In the event that the Participant has elected the alternative specified in Sub-Section 4.2.1(b)(i) above, the Trustee shall transfer to the Participant a written confirmation that the Trustee has received from the Participant the Exercise Price specified in the notice of exercise; and (ii) in the event the Company elects to issue any Common Stock as per Section 7(e)(ii) to the Plan, the Company shall provide the Participant and the Trustee with written notice of its election thereto. The Exercised Stock issued pursuant to this Sub-Section 4.2.3(a) shall be issued in the name of the Trustee and shall be registered in the Trustees name in the Companys books, or alternatively be allocated in the name of the Registration Company and shall be deposited in a trust account in the name of the Trustee (provided, however, that should the Committee determines that any actual payment by or consideration from the Participant should be made (RSU Consideration) no such action shall be taken until such RSU consideration has been provided by the Participant).

 

(b)

In the event that the Participant has elected the alternative specified in Sub-Section 4.2.1(b)(ii) or Sub-Section 4.2.2(i) above, namely, requested to sell on his behalf the Exercised Stock, the Participant shall instruct the Trustee to sell the Exercised Stock at the New York Stock Exchange and, solely with respect to 102 Trustee Options, transfer to the Company the Exercise Price specified in the notice of exercise (provided that should the Restricted Share Units be subject to the provision by the Participant of an RSU Consideration no action pursuant to this Section 4.2.3(b) shall be taken by the Trustee prior to receipt of the entire RSU Consideration from the Participant). Additionally, the Participant shall instruct the Trustee to deduct the amount of taxes (including national insurance and health insurance payments and any other mandatory payment, if applicable) and any other mandatory payments that shall be applicable to the Participant with respect to the exercise of Options, if applicable, and sale of Exercised Stock. The Exercised Stock shall be allocated in the name of the Trustee and shall be registered in the Trustees name in the Companys books, or alternatively be allocated in the name of the Registration Company and shall be transferred to the Trustee, subject to the instructions of the New York Stock Exchange, if any. In the event that the Participant has instructed the Trustee to sell the Exercised Stock, he/she shall not be allowed to cancel his/her notice and instruction, in the event that the exercise and/or sale have been already performed. Upon reception of the consideration from the sale, the Trustee shall use the consideration as follows: (1) deduct from such consideration the amount of tax payments applicable according to law and approvals of the tax authorities and other mandatory payments applicable to the Participant with respect to the exercise of the Options, if applicable, and the sale of the Exercised Stock, in amounts with respect to which the Company has informed the Trustee and shall transfer these amounts to the tax authorities, whether directly or through the Company, as the case may be; (2) deduct from such consideration the Exercise Price or, if applicable, the RSU Consideration, and transfer the Exercise Price or RSU Consideration, as applicable, to the Company; (3) deduct from such consideration the fees to which the Trustee and the performer of the sale are entitled to according to the provisions of the agreement that shall be executed between the Company, the Trustee and the performer of the sale; (4) transfer to the Participants bank account the consideration from the sale after deduction of the applicable amounts specified in sub-sections (1), (2) and (3) above.

 

(c)

In the event that the Participant has elected the alternative specified in Sub-Section 4.2.1(b)(iii) or Sub-Section 4.2.2(ii) above, namely, requested that the Exercised Stock shall be transferred at his/her disposal, he/she shall attach to the notice a written approval by the Trustee that the Trustee has received from the Participant the Exercise Price, or, if applicable, the RSU Consideration, specified in the notice and an approval by the tax assessor that the Participant has paid the income tax applicable to the Participant with respect to the aforesaid transfer of Exercised Stock, in accordance with Section 102, if applicable, or any other law, together with the Companys approval that the Participant has paid the remaining mandatory payments applicable to the Participant. The Trustee shall transfer, whether directly or through the Company, the amount of tax and other mandatory payments to the tax authorities, as the

 

4

 


 

 

case may be, in the relevant date as required by applicable law. Upon the lapse of 15 business days thereafter, the Trustee shall transfer to the Registration Company the Exercised Stock in favor of the Participant and the Company shall apply to the New York Stock Exchange in order to list the aforesaid Exercised Stock for trade at the New York Stock Exchange.

 

(d)

The Company shall be entitled to change, at any time, the exercise procedure and the provisions with respect to the sale, as may be required, in order to moderate and improve the exercise procedure, the exercise and release and the exercise and sale, and adjust them to changes of the applicable law, and in light of the experience that the Company shall have in the future with respect to the operation of such procedures. The Company shall notify the Participants with respect to such changes, in the event that the change is relevant to the Participants. The changes shall be made in coordination with the Trustee, if any and subject to the provisions of Section 102, if applicable and the rules and regulations promulgated there under, in the event that they are applicable to the relevant Participants.

 

4.3    Restrictions on Transfer:

(a)

102 Trustee Awards, or any Exercised Stock issued in respect to the 102 Trustee Awards, and all rights attached thereto (including bonus shares), shall be held by the Trustee for such period of time as required by the provisions of Section 102 applicable to Awards granted through a Trustee in the applicable tax track, as per the Election (the Restricted Period).

 

(b)

Subject to the provisions of Section 102 and any rules or regulation or orders or procedures promulgated thereunder, the Israeli Participant shall provide the Company and the Trustee with a written undertaking and confirmation under which the Israeli Participant confirms that he/she is aware of the provisions of Section 102 and the Elected tax track and agrees to the provisions of the Trust Note executed between the Company and the Trustee, and undertakes not to release, by sale or transfer, the 102 Trustee Awards, and any Exercised Stock issued in respect to the 102 Trustee Awards, and all rights attached thereto (including bonus shares, if any) prior to the lapse of the Restricted Period. The Israeli Participant shall not be entitled to sell or release from trust the 102 Trustee Awards, nor any Exercised Stock issued in respect to the 102 Trustee Awards, nor any right attached thereto (including bonus shares), nor to request the transfer or sale of any of the same to any third party, before the lapse of the Restricted Period. Notwithstanding the above, if any such sale or transfer occurs during the Restricted Period, the sanctions under Section 102 of the Ordinance and under any rules or regulation or orders or procedures promulgated thereunder shall apply to and shall be borne by such Israeli Participant.

 

(c)

Without derogating and subject to the above, and to all other applicable restrictions in the Plan, this Israeli Appendix, the Award Agreement and applicable law, the Trustee shall not release, by sale or transfer, any Exercised Stock issued in respect to 102 Trustee Awards, and all rights attached thereto (including bonus shares) to the Israeli Participant, or to any third party to whom the Israeli Participant wishes to sell the Exercised Stock (unless the contemplated transfer is by will or laws of descent) unless and until the Trustee has either (a) withheld payment of all taxes required to be paid upon the sale or transfer thereof, if any, or (b) received confirmation either that such payment, if any, was remitted to the tax authorities or of another arrangement regarding such payment, which is satisfactory to the Company and the Trustee. For the removal of doubt, it is clarified that the Trustee may release by sale or transfer to a third party only Exercised Stock (and not Awards).

 

4.4     Rights as Stockholder:

Without derogating from the provisions of the Plan, it is hereby further clarified that with respect to Exercised Stock issued pursuant to the exercise of 102 Trustee Options, as long as they are registered in the name of the Trustee, the Trustee shall be the registered owner of such stocks. Notwithstanding, the Trustee shall not exercise the voting rights conferred by such Exercised Stock issued pursuant to the exercise of 102 Trustee Options in any way whatsoever, and shall not issue a proxy to any person or entity to vote such stocks (other than to the applicable Israeli Participant, subject to and in accordance with the provisions of Section 102). Notwithstanding, the Company shall be entitled at its

 

5

 


 

 

sole discretion, and not required, to distribute dividends directly to the Israeli Participants, subject to tax withholding at source.

 

4.5     Bonus Shares:  

All bonus shares to be issued by the Company, if any, with regard to Exercised Stock issued pursuant to the exercise of 102 Trustee Options, while held by the Trustee, shall be registered in the name of the Trustee; and all provisions applying to such Exercised Stock shall apply to bonus shares issued by virtue thereof, if any, mutatis mutandis. Said bonus shares shall be subject to the Restricted Period of the Exercised Stock issued pursuant to the exercise of 102 Trustee Options by virtue of which they were issued. 

 

4.6     Voting:

Without derogating from the provisions of the Plan, solely with respect to Exercised Stock of 102 Trustee Options, such Exercised Stock shall be voted in accordance with the provisions of Section 102.

 

4.7     Conditions of Issuance:

Without derogating from the provisions of Section 13 of the Plan, and in addition thereto, any satisfaction of Withholding Tax Obligation referred to therein shall, in the event of 102 Trustee Awards also need to be satisfactory to the Trustee.

 

5.

102 Non-Trustee Awards

5.1

102 Non-Trustee Awards granted hereunder shall be granted to, and any Exercised Stock issued in connection with such 102 Non-Trustee Awards shall be issued to, the Israeli Participant.

 

5.2

Without derogating and subject to the above, and to all other applicable restrictions in the Plan, this Israeli Appendix, the Award Agreement and applicable law, the Exercised Stock issued with respect to the 102 Non-Trustee Awards, and all rights attached thereto (including, if applicable, bonus shares) shall not be transferred unless and until the Company has either (a) withheld payment of all taxes required to be paid upon the sale or transfer thereof, if any, or (b) received confirmation either that such payment, if any, was remitted to the tax authorities or of another arrangement regarding such payment, which is satisfactory to the Company.

 

5.3

An Israeli Participant to whom 102 Non-Trustee Awards are granted must provide, upon termination of his/her employment, a surety or guarantee to the satisfaction of the Company, to secure payment of all taxes which may become due upon the future transfer of his/her Exercised Stock to be issued in connection with his/her outstanding 102 Non-Trustee Awards, all in accordance with the provisions of Section 102.

 

6.

3(i) Awards

6.1

3(i) Awards granted hereunder shall be granted to, and the Exercised Stock issued pursuant thereto issued to, the Israeli Participant.

 

6.2

Without derogating and subject to the above, and to all other applicable restrictions in the Plan, this Israeli Appendix, the Award Agreement and applicable law, the Exercised Stock issued in connection with the 3(i) Awards, and all rights attached thereto (including, as applicable, bonus shares) shall not be transferred unless and until the Company has either (a) withheld payment of all taxes required to be paid upon the sale or transfer thereof, if any, or (b) received confirmation either that such payment, if any, was remitted to the tax authorities or of another arrangement regarding such payment, which is satisfactory to the Company.

 

6.3

The Company may require, as a condition to the grant of the 3(i) Awards, that an Israeli Participant to whom 3(i) Awards are to be granted, provide a surety or guarantee to the satisfaction of the Company, to secure payment of all taxes which may become due upon the future transfer of his/her Exercised Stock to be issued in connection with his/her outstanding 3(i) Awards.  

 

6

 


 

 

7.

Tax Consequences

Without derogating from and in addition to any provisions of the Plan, any and all tax and/or other mandatory payment consequences arising from the grant or, as applicable, exercise of Awards, the payment for or the transfer or sale of Exercised Stock, or from any other event or act in connection therewith (including without limitation, in the event that the Awards do not qualify under the tax classification/tax track in which they were intended) whether of the Company, an Affiliated Company, the Trustee or the Israeli Participant, including without limitation any non-compliance of the Israeli Participant with the provisions hereof, shall be borne solely by the Israeli Participant. The Company, any applicable Affiliated Company, and the Trustee, may each withhold (including at source), deduct and/or set-off, from any payment made to the Israeli Participant, the amount of the taxes and/or other mandatory payments of which is required with respect to the Awards and/or Exercised Stock. Furthermore, each Israeli Participant shall indemnify the Company, the applicable Affiliated Company and the Trustee, or any one thereof, and to hold them harmless from any and all liability for any such tax and/or other mandatory payments or interest or penalty thereupon, including without limitation liabilities relating to the necessity to withhold, or to have withheld, any such tax and/or other mandatory payments from any payment made to the Israeli Participant.

 

Without derogating from the aforesaid, each Israeli Participant shall provide the Company and/or any applicable Affiliated Company with any executed documents, certificates and/or forms that may be required from time to time by the Company or such Affiliated Company in order to determine and/or establish the tax liability of such Israeli Participant.  

 

Without derogating from the foregoing, it is hereby clarified that the Israeli Participant shall bear and be liable for all tax and other consequences in the event that his/her 102 Trustee Awards and/or the Exercised Stock issued in connection thereof, as applicable, are not held for the entire Restricted Period, all as provided in Section 102.

 

The Company and/or when applicable the Trustee shall not be required to release any share certificate to an Israeli Participant until all required payments have been fully made.

 

8.

Currency Exchange Rates

Except as otherwise determined by the Board and/or the Committee, all monetary values with respect to Awards granted pursuant to this Israeli Appendix, including without limitation the Fair Market Value and, if applicable, the Exercise Price of each Award, shall be stated in United States Dollars. In the event that the Exercise Price is in fact to be paid in New Israeli Shekels, at the sole discretion of the Board and/or the Committee, the conversion rate shall be the last known representative rate (published by the Bank of Israel) of the U.S. Dollars to the New Israeli Shekels on the date of payment.

 

 

9.

Subordination to the Ordinance

9.1

It is clarified that the grant of the 102 Trustee Awards hereunder is subject to the approval by the Tax Authorities of the Plan, this Israeli Appendix and the Trustee, in accordance with Section 102.

 

9.2

Any provisions of the Section 102 or Section 3(i) of the Ordinance and/or any of the rules or regulations promulgated thereunder, which is not expressly specified in the Plan or in the applicable Award Agreement, including without limitation any such provision which is necessary in order to receive and/or to keep any tax benefit, shall be deemed incorporated into this Israeli Appendix and binding upon the Company, and applicable Affiliated Company and the Israeli Participant.

 

9.3

With regards to 102 Trustee Awards, the provisions of the Plan and/or this Israeli Appendix and/or the Award Agreement shall be subject to the provisions of Section 102 and the Tax Assessing Officers permit, and the said provisions and permit shall be deemed an integral part of the Plan and of this Israeli Appendix and of the Award Agreement.

 

7

 


 

 

9.4

The Awards, the Plan, this Israeli Appendix and any applicable Award Agreements are subject to the applicable provisions of the Ordinance, which shall be deemed an integral part of each, and which shall prevail over any term that is inconsistent therewith.

 

10.

Governing Law & Jurisdiction

10.1

This Israeli Appendix shall be governed by and construed and enforced in accordance with the laws of the State of Israel applicable to contracts made and to be performed therein, without giving effect to the principles of conflict of laws. The competent courts of the city of Tel Aviv, Israel shall have sole jurisdiction in any matters pertaining to this Israeli Appendix, to exclude all other courts.

 

11.

Other Terms

11.1

All other term and conditions not specifically amended or changed by virtue of this Israeli Appendix shall remain valid and enforceable.

 

 

8

 


Exhibit 31.1

 

Certification of

Principal Executive Officer of

3D Systems Corporation

 

I, Abraham N. Reichental, certify that:

 

1)

I have reviewed this report on Form 10-Q of 3D Systems Corporation;

 

2)

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3)

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4)

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5)

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

By: 

/s/  Abraham N. Reichental

 

Abraham N. Reichental

 

Title: President and Chief Executive Officer

 

        (principal executive officer)

 

Date: May 6, 2015


Exhibit 31.2

 

Certification of

Principal Financial Officer of

3D Systems Corporation

 

I, Theodore A. Hull, certify that:

 

1)

I have reviewed this report on Form 10-Q of 3D Systems Corporation;

 

2)

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3)

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4)

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5)

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

 

 

By: 

/s/  Theodore A. Hull

 

Theodore  A. Hull

 

Title: Executive Vice President and Chief Financial Officer

 

(principal financial officer)

 

Date: May 6, 2015


Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and accompanies the Quarterly Report on Form 10-Q (the “Form 10-Q”) for the quarter ended March 31, 2015 of 3D Systems Corporation (the “Issuer”).

 

I, Abraham N. Reichental, the President and Chief Executive Officer (principal executive officer) of the Issuer, certify that, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge:

 

i.   the Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

 

ii.   the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer.

 

 

/s/  Abraham N. Reichental

Name: Abraham N. Reichental

 

Date: May 6, 2015

 

A signed original of this written statement required by Section 906 has been provided to 3D Systems Corporation and will be retained by 3D Systems Corporation and furnished to the Securities and Exchange Commission or its staff upon request.


Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and accompanies the Quarterly Report on Form 10-Q (the “Form 10-Q”) for the quarter ended March 31, 2015 of 3D Systems Corporation (the “Issuer”).

 

I, Theodore A. Hull, the Executive Vice President and Chief Financial Officer (principal financial officer) of the Issuer, certify that, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge:

 

i.   the Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

 

ii.   the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer.

 

 

/s/  Theodore  A. Hull

Name: Theodore A. Hull

 

Date: May 6, 2015

 

A signed original of this written statement required by Section 906 has been provided to 3D Systems Corporation and will be retained by 3D Systems Corporation and furnished to the Securities and Exchange Commission or its staff upon request.

 




Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings